##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



---



FORM 10-Q



---



(Mark One)

|x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------------



For the Quarterly Period Ended June 30, 2005



OR



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
|- | --------------------------------------------------------------------------------------------



For the transition period from  to
.



Commission File Number 000-31081



---



TRIPATH TECHNOLOGY INC.

(Exact name of registrant as specified in its charter)



---



|                                                               |  |                                     
|-------------------------------------------------------------- |  | ------------------------------------
|Delaware                                                       |  | 77-0407364                          
|(State or other jurisdiction of Incorporation or Organization) |  | (I.R.S. Employer Identification No.)



2560 Orchard Parkway

San Jose, California 95131

(Address of Principal Executive Office including (Zip Code)



(408) 750-3000

(Registrants telephone number, including area code)



---



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (Exchange Act) during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No ̈



Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule
12b-2).    Yes  x    No ̈



55,385,202 shares of the Registrants common stock were outstanding as of August 5,
2005.



---



---

##### Table of Contents

TABLE OF CONTENTS



|         |  |                                                                                                                               |  |   
|-------- |  | ----------------------------------------------------------------------------------------------------------------------------- |  | --
|PART I.  |  | Financial Information                                                                                                         |  | 3 
|         |  |                                                                                                                              
|         |  | Item 1. Financial Statements                                                                                                  |  | 3 
|         |  |                                                                                                                              
|         |  | Condensed Consolidated Balance Sheets as of June 30, 2005 (unaudited) and September 30, 2004                                  |  | 3 
|         |  |                                                                                                                              
|         |  | Condensed Consolidated Statements of Operations for the three months and nine months ended June 30, 2005 and 2004 (unaudited) |  | 4 
|         |  |                                                                                                                              
|         |  | Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2005 and 2004 (unaudited)                  |  | 5 
|         |  |                                                                                                                              
|         |  | Notes to Condensed Interim Consolidated Financial Statements                                                                  |  | 6 
|         |  |                                                                                                                              
|         |  | Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations                                 |  | 21
|         |  |                                                                                                                              
|         |  | Risk Factors                                                                                                                  |  | 28
|         |  |                                                                                                                              
|         |  | Item 3. Quantitative and Qualitative Disclosures about Market Risk                                                            |  | 39
|         |  |                                                                                                                              
|         |  | Item 4. Controls and Procedures                                                                                               |  | 40
|         |  |                                                                                                                              
|PART II. |  | Other Information                                                                                                             |  | 43
|         |  |                                                                                                                              
|         |  | Item 1. Legal Proceedings                                                                                                     |  | 43
|         |  |                                                                                                                              
|         |  | Item 6. Exhibits                                                                                                              |  | 44
|         |  |                                                                                                                              
|         |  | Signatures                                                                                                                    |  | 45
|         |  |                                                                                                                              
|         |  | Exhibit Index                                                                                                                 |  | 46



2



---

##### Table of Contents

PART I. Financial Information



Item 1. Financial Statements



TRIPATH TECHNOLOGY INC.



CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)



|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------------------------ | -------- | - | ------------------------------------ | - | -------- | -
|                                                                                                                                                                                         |  | June 30, 2005(Unaudited) |          |   | September 30, 2004 Restated(Audited) |  
|ASSETS                                                                                                                                                                                   |  |                          |          |   |                                      |   |          |  
|Current assets:                                                                                                                                                                          |  |                          |          |   |                                      |   |          |  
|Cash, cash equivalents and restricted cash                                                                                                                                               |  | $                        | 2,224    |   |                                      | $ | 7,339    |  
|Accounts receivable, net                                                                                                                                                                 |  |                          | 972      |   |                                      |   | 1,019    |  
|Inventories, net                                                                                                                                                                         |  |                          | 3,672    |   |                                      |   | 3,939    |  
|Prepaid expenses and other current assets                                                                                                                                                |  |                          | 2,273    |   |                                      |   | 212      |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Total current assets                                                                                                                                                                     |  |                          | 9,141    |   |                                      |   | 12,509   |  
|                                                                                                                                                                                         |  |                         
|Property and equipment, net                                                                                                                                                              |  |                          | 1,053    |   |                                      |   | 1,674    |  
|Other assets                                                                                                                                                                             |  |                          | 129      |   |                                      |   | 123      |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Total assets                                                                                                                                                                             |  | $                        | 10,323   |   |                                      | $ | 14,306   |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|LIABILITIES AND STOCKHOLDERS EQUITY                                                                                                                                                     |  |                          |          |   |                                      |   |          |  
|Current liabilities:                                                                                                                                                                     |  |                          |          |   |                                      |   |          |  
|Accounts payable                                                                                                                                                                         |  | $                        | 1,996    |   |                                      | $ | 2,908    |  
|Current portion of capital lease obligations                                                                                                                                             |  |                          | 207      |   |                                      |   | 664      |  
|Current portion of deferred rent                                                                                                                                                         |  |                          | 295      |   |                                      |   | 266      |  
|Accrued expenses                                                                                                                                                                         |  |                          | 2,901    |   |                                      |   | 764      |  
|Deferred distributor revenue                                                                                                                                                             |  |                          | 1,335    |   |                                      |   | 1,075    |  
|Warrant liability                                                                                                                                                                        |  |                          | 503      |   |                                      |   |         |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Total current liabilities                                                                                                                                                                |  |                          | 7,237    |   |                                      |   | 5,677    |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Long term liabilities                                                                                                                                                                    |  |                          | 294      |   |                                      |   | 571      |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Commitments and contingencies (see Note 13)                                                                                                                                              |  |                          |          |   |                                      |   |          |  
|                                                                                                                                                                                         |  |                         
|Stockholders equity:                                                                                                                                                                    |  |                          |          |   |                                      |   |          |  
|Common stock, $0.001 par value, 100,000,000 shares authorized; 55,355,685 and 50,043,158 shares issued and outstanding at June 30, 2005
(unaudited) and September 30, 2004, respectively |  |                          | 55       |   |                                      |   | 49       |  
|Additional paid-in capital                                                                                                                                                               |  |                          | 202,451  |   |                                      |   | 199,333  |  
|Deferred stock-based compensation                                                                                                                                                        |  |                          |         |   |                                      |   | (95      | )
|Accumulated deficit                                                                                                                                                                      |  |                          | (199,714 | ) |                                      |   | (191,229 | )
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Total stockholders equity                                                                                                                                                               |  |                          | 2,792    |   |                                      |   | 8,058    |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  
|Total liabilities and stockholders equity                                                                                                                                               |  | $                        | 10,323   |   |                                      | $ | 14,306   |  
|                                                                                                                                                                                         |  |                          |          |   |                                      |   |          |  



The accompanying notes
are an integral part of these condensed interim consolidated financial statements.





3



---

##### Table of Contents

TRIPATH TECHNOLOGY INC.



CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

Unaudited



|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|----------------------------------------------------------------------------------------------- |  | --------------------------- | ------ | - | -------------------------- | - | ------ | ---- |  | - | ------------ | - |  | - | ------ | -
|                                                                                                |  | Three Months Ended June 30, |        |   | Nine Months Ended June 30, |  
|                                                                                                |  | 2005                        |        |   | 2004 Restated              |   |        | 2005 |  |   | 2004Restated |  
|Revenue                                                                                         |  | $                           | 2,886  |   |                            | $ | 2,601  |      |  | $ | 7,287        |   |  | $ | 10,000 |  
|Cost of revenue                                                                                 |  |                             | 1,314  |   |                            |   | 2,334  |      |  |   | 3,531        |   |  |   | 7,476  |  
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Gross profit                                                                                    |  |                             | 1,572  |   |                            |   | 267    |      |  |   | 3,756        |   |  |   | 2,524  |  
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Operating expenses:                                                                             |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Research and development                                                                        |  |                             | 1,742  |   |                            |   | 1,876  |      |  |   | 5,605        |   |  |   | 5,263  |  
|Selling, general and administrative                                                             |  |                             | 3,866  |   |                            |   | 1,154  |      |  |   | 7,084        |   |  |   | 3,505  |  
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Total operating expenses                                                                        |  |                             | 5,608  |   |                            |   | 3,030  |      |  |   | 12,689       |   |  |   | 8,768  |  
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Loss from operations                                                                            |  |                             | (4,036 | ) |                            |   | (2,763 | )    |  |   | (8,933       | ) |  |   | (6,244 | )
|Change in fair value on revaluation of warrant liability                                        |  |                             | 213    |   |                            |   |       |      |  |   | 465          |   |  |   |       |  
|Interest and other expense, net                                                                 |  |                             | (6     | ) |                            |   | (40    | )    |  |   | (17          | ) |  |   | (24    | )
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Net loss                                                                                        |  | $                           | (3,829 | ) |                            | $ | (2,803 | )    |  | $ | (8,485       | ) |  | $ | (6,268 | )
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Basic and diluted net loss per share                                                            |  | $                           | (0.07  | ) |                            | $ | (0.06  | )    |  | $ | (0.16        | ) |  | $ | (0.13  | )
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  
|Weighted average number of common shares used in computing basic and diluted net loss per share |  |                             | 55,351 |   |                            |   | 45,878 |      |  |   | 53,646       |   |  |   | 46,615 |  
|                                                                                                |  |                             |        |   |                            |   |        |      |  |   |              |   |  |   |        |  



The accompanying notes
are an integral part of these condensed interim consolidated financial statements.



4



---

##### Table of Contents

TRIPATH TECHNOLOGY INC.



CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Unaudited



|                                                                            |  |                           |        |   |              |   |        |  
|--------------------------------------------------------------------------- |  | ------------------------- | ------ | - | ------------ | - | ------ | -
|                                                                            |  | Nine Months EndedJune 30, |       
|                                                                            |  | 2005                      |        |   | 2004Restated |  
|Cash flows from operating activities:                                       |  |                           |        |   |              |   |        |  
|Net loss                                                                    |  | $                         | (8,485 | ) |              | $ | (6,268 | )
|Adjustments to reconcile net loss to net cash used in operating activities: |  |                           |        |   |              |   |        |  
|Change in fair value on revaluation of warrant liability                    |  |                           | (465   | ) |              |   |       |  
|Depreciation and amortization                                               |  |                           | 669    |   |              |   | 839    |  
|Deferred Rent                                                               |  |                           | (192   | ) |              |   | 156    |  
|Allowance for doubtful accounts                                             |  |                           | (50    | ) |              |   |       |  
|Provision for slow moving, excess and obsolete inventory                    |  |                           |       |   |              |   | 498    |  
|Stock-based compensation                                                    |  |                           | 95     |   |              |   | 128    |  
|Changes in assets and liabilities:                                          |  |                           |        |   |              |   |        |  
|Accounts receivable, net                                                    |  |                           | 97     |   |              |   | (812   | )
|Inventories, net                                                            |  |                           | 267    |   |              |   | (5,525 | )
|Prepaid expenses and other assets                                           |  |                           | (2,067 | ) |              |   | (46    | )
|Accounts payable                                                            |  |                           | (912   | ) |              |   | 1,321  |  
|Accrued expenses                                                            |  |                           | 2,137  |   |              |   | 16     |  
|Deferred distributor revenue                                                |  |                           | 260    |   |              |   | 2,728  |  
|                                                                            |  |                           |        |   |              |   |        |  
|Net cash used in operating activities                                       |  |                           | (8,646 | ) |              |   | (6,965 | )
|                                                                            |  |                           |        |   |              |   |        |  
|Cash flows from investing activities:                                       |  |                           |        |   |              |   |        |  
|Purchase of property and equipment                                          |  |                           | (48    | ) |              |   | (610   | )
|                                                                            |  |                           |        |   |              |   |        |  
|Net cash used in investing activities                                       |  |                           | (48    | ) |              |   | (610   | )
|                                                                            |  |                           |        |   |              |   |        |  
|Cash flows from financing activities:                                       |  |                           |        |   |              |   |        |  
|Net proceeds from issuance of common stock                                  |  |                           | 4,092  |   |              |   | 4,320  |  
|Principal payments on capital lease obligations                             |  |                           | (513   | ) |              |   | (348   | )
|                                                                            |  |                           |        |   |              |   |        |  
|Net cash provided by financing activities                                   |  |                           | 3,579  |   |              |   | 3,972  |  
|                                                                            |  |                           |        |   |              |   |        |  
|Net decrease in cash and cash equivalents                                   |  |                           | (5,115 | ) |              |   | (3,603 | )
|Cash, cash equivalents, and restricted cash, beginning of period            |  |                           | 7,339  |   |              |   | 9,088  |  
|                                                                            |  |                           |        |   |              |   |        |  
|Cash, cash equivalents, and restricted cash, end of period                  |  | $                         | 2,224  |   |              | $ | 5,485  |  
|                                                                            |  |                           |        |   |              |   |        |  
|Non-cash financing activity:                                                |  |                           |        |   |              |   |        |  
|Property and equipment acquired by capital lease                            |  | $                         |       |   |              | $ | 317    |  
|                                                                            |  |                           |        |   |              |   |        |  



The accompanying notes
are an integral part of these condensed interim consolidated financial statements.



5



---

##### Table of Contents

Tripath Technology Inc.



Notes to
Condensed Interim Consolidated Financial Statements

(Unaudited)



1. Basis of Presentation



The unaudited condensed interim consolidated financial statements included herein have been prepared by Tripath Technology Inc. (the Company) in accordance
with accounting principles generally accepted in the United States of America and reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to state fairly the Companys financial
position, results of operations and cash flows for the periods presented. These interim financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Companys Transition
Report on Form 10-K/T/A as restated (refer to Note 16) for the transition period ended September 30, 2004 filed on July 27, 2005. The results of operations for the three and nine months ended June 30, 2005 are not necessarily indicative of the
results to be expected for any subsequent quarter or for the entire year.



On
November 14, 2004, Tripaths Board of Directors approved a change in the Companys fiscal year end from December 31 to September 30, effective as of September 30, 2004.



The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates, and such differences may be material to the financial statements.



The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned Japanese subsidiary, which was incorporated in
January 2001. All significant intercompany balances and transactions have been eliminated in consolidation. The U.S. dollar is the functional currency for the Companys Japanese wholly-owned subsidiary. Assets and liabilities that are not
denominated in the functional currency are remeasured into U.S. dollars and the resulting gains or losses are included in Interest and other income, net. Such gains or losses have not been material for any period presented.



The Companys consolidated financial statements have been prepared on the basis of a
going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred substantial losses and has experienced negative cash flow since inception and has an
accumulated deficit of $199.7 million at June 30, 2005.



Beginning in August
2001, the Company instituted programs to reduce expenses including reducing headcount from 144 employees at the end of July 2001 to 66 employees at the end of June 2005 and reducing employees salaries by 10%. In September 2002 the Company
relocated its headquarters which reduced rent expense and canceled its D&O policy which reduced insurance expense. These actions resulted in significant cost savings in 2003. The Company reduced its cash used in operating activities from
approximately $13.0 million in 2002 to approximately $4.1 million in 2003. However, for the nine months ended September 30, 2004, cash used in operating activities increased to $9.1 million. For the nine months ended June 30, 2005, cash used in
operating activities was $8.6 million.



During 2004, warrants were exercised
which resulted in the Company receiving proceeds totaling approximately $2.3 million. In addition, in August 2004 we raised $5.0 million through financing and in March 2005 we raised $4.0 million through a private placement. At June 30, 2005, the
Company had working capital of $1.9 million, including cash of $2.2 million.



The Company is aware that its existing working capital at June 30, 2005 may not be sufficient to meet its operating, working capital, investing and financing requirements for the next twelve months. The Company has not made any adjustment
to its consolidated financial statements as a result of the potential outcome of the uncertainty described above.



6



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



The Company will need to raise additional funds to finance its activities through public or private equity or debt
financings, the formation of strategic partnerships or alliances with other companies or through bank borrowings with existing or new banks. The Company may not be able to obtain additional funds on terms that would be favorable to the Company and
its stockholders, or at all. In such instance, the Company will take measures to reduce its operating expenses, such as reducing headcount or canceling selected research and development projects. Without sufficient capital to fund its operations,
the Company will no longer be able to continue as a going concern. The Company believes, based on its current cash balance as well as its ability to implement the aforementioned measures, if needed, that the Company will have liquidity sufficient to
meet its operating, working capital and financing needs for the next twelve months and perhaps beyond. The Companys long-term prospects are dependent upon obtaining sufficient financing as needed to fund current working capital needs and
future growth, and ultimately on achieving profitability.



2.
Revenue recognition



The Company recognizes revenue in accordance with
Securities and Exchange Commission Staff Accounting Bulletin No. 104 (SAB 104), Revenue Recognition. The Company recognizes revenue when all of the following criteria are met: 1) there is persuasive evidence that an
arrangement exists, 2) delivery of goods has occurred, 3) the sales price is fixed or determinable, and 4) collectibility is reasonably assured. The following policies apply to the Companys major categories of revenue transactions.



Sales to OEM Customers: Under the Companys standard terms and conditions of
sale, title and risk of loss transfer to the customer at the time product is shipped to the customer, FOB shipping point, and revenue is recognized accordingly. The Company accrues the estimated cost of post-sale obligations, including basic product
warranties or returns, based on historical experience. The Company has experienced minimal warranty or other returns to date.



Sales to Distributors: Sales to distributors are made under arrangements allowing limited rights of return, generally under product warranty provisions, stock
rotation rights and price protection on products unsold by the distributor. In addition, the distributor may request special pricing and allowances which may be granted subject to the companys approval. As a result of these return rights and
potential pricing adjustments, the Company generally defers recognition of revenue until such time that the distributor sells product to its customer based upon receipt of point-of-sale reports from the distributor.



3. Net loss per share



Basic net loss per share is computed by dividing the net loss attributable to common
stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common stock and dilutive potential common stock outstanding.
The calculation of diluted net loss per share excludes potential common stock if the effect is anti-dilutive. Potential common stock consists of incremental common stock issuable upon the exercise of stock options and common stock issuable upon the
exercise of common stock warrants.



Total potential common stock of 11,666,000
and 10,597,000 shares were not included in the diluted net loss per share calculation for the three and nine month periods ended June 30, 2005, respectively, because to do so would be anti-dilutive. For the three and nine month periods ended June
30, 2004, 8,676,000 and 8,128,000 shares of potential common stock were excluded from the calculation of diluted net loss per share because they were anti-dilutive.





7



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in
thousands, except per share amounts):



|                              |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|----------------------------- |  | --------------------------- | ------ | - | -------------------------- | - | ------ | ---- |  | - | ------------- | - |  | - | ------ | -
|                              |  | Three months ended June 30, |        |   | Nine months ended June 30, |  
|                              |  | 2005                        |        |   | 2004Restated               |   |        | 2005 |  |   | 2004 Restated |  
|Numerator:                    |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|Net loss                      |  | $                           | (3,829 | ) |                            | $ | (2,803 | )    |  | $ | (8,485        | ) |  | $ | (6,268 | )
|                              |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|Denominator:                  |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|Weighted average common stock |  |                             | 55,351 |   |                            |   | 45,878 |      |  |   | 53,646        |   |  |   | 46,615 |  
|                              |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|Net loss per share:           |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  
|Basic and diluted             |  | $                           | (0.07  | ) |                            | $ | (0.06  | )    |  | $ | (0.16         | ) |  | $ | (0.13  | )
|                              |  |                             |        |   |                            |   |        |      |  |   |               |   |  |   |        |  



4. Deferred
stock-based compensation



The Company recognized deferred stock-based
compensation in connection with certain employee stock option grants and the issuance of restricted stock. The deferred stock-based compensation related to the employee stock option grants is being amortized over the vesting periods of the related
options, generally four years, using an accelerated basis while the deferred stock-based compensation related to the issuance of restricted stock is being amortized over two years on a straight line basis. The fair value per share used to calculate
deferred stock-based compensation was derived by reference to the share quoted price. Future compensation charges are subject to reduction for any employee who terminates employment prior to such employees option vesting date.



The Company has granted options to purchase shares of common stock to consultants in exchange
for services. The Company determined the value of the options granted to consultants based on the Black-Scholes option pricing model.



The following table sets forth, for each of the periods presented, the deferred stock-based compensation recorded and the amortization of deferred stock-based
compensation (in thousands):



|                                                  |  |                             |    |                           |   |      |  |      |    |  |   |    
|------------------------------------------------- |  | --------------------------- | -- | ------------------------- | - | ---- |  | ---- | -- |  | - | ---
|                                                  |  | Three months ended June 30, |    | Nine months endedJune 30,
|                                                  |  | 2005                        |    | 2004                      |   | 2005 |  | 2004
|Deferred stock-based compensation                 |  | $                           |   |                           | $ |     |  | $    |   |  | $ | 6  
|Amortization of deferred stock-based compensation |  | $                           | 14 |                           | $ | 41   |  | $    | 95 |  | $ | 128



Unamortized deferred stock-based
compensation at June 30, 2005 and September 30, 2004 was $0 and $95,000 respectively.



5. Accounting for stock-based compensation



The Company accounts for its stock-based compensation plans under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations. No stock-based
employee compensation cost is reflected in net income for the periods ended June 30, 2005 and 2004, as all options granted under those plans had an exercise price that was at least equal to the market value of the underlying common stock on the date
of grant.





8



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



The following table illustrates the effect on net loss and loss per share as if the Company had applied the fair
value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation to stock-based employee compensation.



|                                                                                                                                                            |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  
|----------------------------------------------------------------------------------------------------------------------------------------------------------- |  | -------------------------- | ------ | - | ------------------------- | - | ------ | ---- |  | - | ------- | - |  | - | ------ | -
|                                                                                                                                                            |  | Three months endedJune 30, |        |   | Nine months endedJune 30, |  
|                                                                                                                                                            |  | 2005                       |        |   | 2004Restated              |   |        | 2005 |  |   | 2004    |  
|Net loss applicable to common stockholders, as reported                                                                                                     |  | $                          | (3,829 | ) |                           | $ | (2,803 | )    |  | $ | (8,485  | ) |  | $ | (6,268 | )
|Total stock-based employee compensation expense included in the net loss, determined under the recognition and measurement principles of APB
Opinion No. 25 |  |                            | 14     |   |                           |   | 41     |      |  |   | 95      |   |  |   | 128    |  
|Total stock-based employee compensation expense determined under fair value based method for all awards                                                     |  |                            | (681   | ) |                           |   | (659   | )    |  |   | (2,045  | ) |  |   | (1,846 | )
|                                                                                                                                                            |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  
|Pro forma net loss applicable to common stockholders                                                                                                        |  | $                          | (4,496 | ) |                           | $ | (3,421 | )    |  | $ | (10,435 | ) |  | $ | (7,986 | )
|                                                                                                                                                            |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  
|Loss per share:                                                                                                                                             |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  
|Basic and dilutedas reported                                                                                                                               |  | $                          | (0.07  | ) |                           | $ | (0.06  | )    |  | $ | (0.16   | ) |  | $ | (0.13  | )
|                                                                                                                                                            |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  
|Basic and dilutedpro forma                                                                                                                                 |  | $                          | (0.08  | ) |                           | $ | (0.07  | )    |  | $ | (0.19   | ) |  | $ | (0.17  | )
|                                                                                                                                                            |  |                            |        |   |                           |   |        |      |  |   |         |   |  |   |        |  



6. Cash, cash
equivalents and restricted cash



The Company considers all highly liquid
investments with a maturity of three months or less from the date of purchase to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market funds, the fair value of which approximates cost.



The Company has entered into a Security Agreement to provide collateral for an outstanding
standby letter of credit which totaled approximately $160,000 at June 30, 2005. The collateral is considered restricted cash.



7. Concentration of credit risk and significant customers



Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments.
Substantially all of the Companys cash and cash equivalents are invested in highly-liquid money market funds with major financial institutions. The Company sells its products through distributors and directly to original equipment
manufacturers. The Company performs periodic credit evaluations of its customers and maintains an allowance for potential credit losses, as considered necessary by management. Credit losses to date have been consistent with managements
estimates. During the quarters ended June 30, 2005 and 2004, the Company had minimal bad debts write-offs.



The following table summarizes sales to end customers comprising 10% or more of the Companys total revenue for the periods indicated:



|           |  |                                                 |   |  |                                                |   |  |      |   |  |      |  
|---------- |  | ----------------------------------------------- | - |  | ---------------------------------------------- | - |  | ---- | - |  | ---- | -
|           |  | % of Revenue for the ThreeMonths Ended June 30, |   |  | % of Revenue for the NineMonths Ended June 30, |  
|           |  | 2005                                            |   |  | 2004                                           |   |  | 2005 |   |  | 2004 |  
|Customer A |  | 21                                              | % |  | 3                                              | % |  | 18   | % |  | 2    | %
|Customer B |  | 4                                               | % |  | 32                                             | % |  | 5    | % |  | 13   | %
|Customer C |  | 1                                               | % |  | 12                                             | % |  |     |   |  | 19   | %
|Customer D |  | 5                                               | % |  |                                               |   |  | 8    | % |  | 24   | %
|Customer E |  | 1                                               | % |  | 10                                             | % |  | 2    | % |  | 6    | %



9



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



The Companys accounts receivable were concentrated with three customers at June 30, 2005 representing 63%, 13%,
and 12% of aggregate gross receivables and with four customers at September 30, 2004 representing 46%, 16%, 9% and 9% of aggregate gross receivables.



8. Inventories



Inventories are stated at the lower of cost or market. This policy requires the Company to make estimates regarding the market value of the Companys inventory,
including an assessment of excess or obsolete inventory. The Company determines excess and obsolete inventory based on an estimate of the future demand and estimated selling prices for the Companys products within a specified time horizon,
generally 12 months. The estimates the Company uses for expected demand are also used for near-term capacity planning and inventory purchasing and are consistent with the Companys revenue forecasts. Actual demand and market conditions may be
different from those projected by the Companys management. If the Companys unit demand forecast is less than the Companys current inventory levels and purchase commitments, during the specified time horizon, or if the estimated
selling price is less than the Companys inventory value, the Company will be required to take additional excess inventory charges or write-downs to the net realizable value which will decrease the Companys gross margin and net operating
results in the future. During the quarter ended March 31, 2002, the Company recorded a provision for slow moving, excess, and obsolete inventory of approximately $5.0 million related to excess inventory for the Companys TA2022 product as a
result of a decrease in forecasted sales for this product. In fiscal 2004, the Company increased the inventory reserves by an additional $4.3 million from $4.9 million to $9.2 million to account for slow moving, excess, and obsolete inventory. The
additional inventory charge related to slow-moving and excess inventory for our TA1101B, TA3020, TA2041, TA2022 and leaded TA2024 products, the TK2350, TK2051, TK2150, TK2050 and TK2052 chipsets, and Kauai 2BB and U461 die based on a decline in
forecasted sales for these parts. During the quarters ended March 31, 2005 and June 30, 2005, the Company sold inventory for which net amounts of approximately $1.5 million and $1.2 million, respectively of inventory reserves were previously
provided.



Inventories, net, are comprised of the following (in thousands):



|                                                             |  |              |        |   |                             |   |        |  
|------------------------------------------------------------ |  | ------------ | ------ | - | --------------------------- | - | ------ | -
|                                                             |  | June 30,2005 |        |   | September 30, 2004 Restated |  
|Raw materials                                                |  | $            | 7,382  |   |                             | $ | 6,668  |  
|Work-in-process                                              |  |              | 369    |   |                             |   | 847    |  
|Finished goods                                               |  |              | 1,395  |   |                             |   | 4,938  |  
|Inventory held by distributors                               |  |              | 1,014  |   |                             |   | 685    |  
|Less: reserve for slow-moving, excess and obsolete inventory |  |              | (6,488 | ) |                             |   | (9,199 | )
|                                                             |  |              |        |   |                             |   |        |  
|Total                                                        |  | $            | 3,672  |   |                             | $ | 3,939  |  
|                                                             |  |              |        |   |                             |   |        |  



9. Accrued
Expenses



The Company has accrued approximately $1.8 million related to
the legal settlement that was reached on July 11, 2005 (see Note 16). The $1.8 million is comprised of $200,000 for the cash payment that will be made and approximately $1.6 million for the 2,450,000 shares of common stock that will be issued as
part of the settlement. The accrual for the issuance of common stock was calculated using $0.65 per share, which was the closing price of the Companys stock as of June 30, 2005. When the shares of common stock are issued, the liability
calculated using the closing price of the common stock at the date of issuance will be reclassified to stockholders equity and the corresponding S, G&A expense will be revised accordingly.



10. Warrant liability



On March 3, 2005, the Company completed a private placement which resulted in gross proceeds
of $4.4 million. In connection with this private placement the Company sold 4,833,335 shares of common stock at a price of $0.90 per share and issued warrants to purchase up to 966,667 shares of common stock. The warrants have a term of 3.5 years
and an exercise price equal to $1.25. Since the warrants are subject to certain registration rights, the Company recorded a warrant liability, totaling $967,000, in accordance with EITF 00-19 Accounting for Derivative Financial Instruments
Indexed to, and Potentially Settled in, a Companys Own Stock. The warrant liability has subsequently been recalculated using the closing price of the Companys common stock as of June 30, 2005. The registration rights provide for
the Company to file with the Securities and Exchange Commission a Registration Statement covering the resale of all of the securities issued in connection



10



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



with the private placement. The Company is subject to certain penalties if the Registration Statement is not declared effective by the stipulated deadline.
The Company valued the warrants using the Black-Scholes option pricing model, applying a life of 3.5 years, a risk free interest rate of 4.02%, an expected dividend yield of 0%, a volatility of 154% and a deemed fair value of common stock of $1.17
which was the closing price of the Companys common stock on March 3, 2005. In accordance with SFAS 133 Accounting for Derivative Instruments and Hedging Activities, the Company revalued the warrants as of June 30, 2005 using the
Black-Scholes option pricing model. Assumptions regarding the life, the expected dividend yield and volatility were left unchanged but the Company did apply a risk free interest rate of 3.72% and a deemed fair value of common stock of $0.65, which
was the closing price of the Companys common stock on June 30, 2005. The difference between the fair value of the warrants as of June 30, 2005 and the previous valuation as of March 31, 2005 has been recorded as a change in fair value on
revaluation of warrant liability. Upon the registration statement covering the shares underlying the warrants being declared effective, the fair value of the warrants on that date will be reclassified to equity.



11. Common Stock



In March 2005 the Company completed a private placement of common stock and common stock
purchase warrants with certain institutional investors. The Company agreed to sell an aggregate of approximately 4,833,335 shares of common stock at $0.90 per share. The investors will also receive warrants to purchase an aggregate of approximately
966,667 shares of the Companys common stock at an exercise price of $1.25 per share.



On March 2, 2005 the Company entered into a Severance Agreement and Release (the Agreement) with its former Chief Financial Officer. Pursuant to the Agreement, the vesting of the former Chief Financial
Officers stock options was accelerated so that options to purchase 75,000 shares of the Companys common stock became fully vested and exercisable. Such options have an exercise price of $1.85 per share and are exercisable at any time up
to September 15, 2005. The Company has recorded compensation expense totaling $19,000 related to the acceleration of the vesting of these options.



12. Segment and geographic information



The Company has determined that it has one reportable business segment: the design, license and marketing of integrated circuits.



The following is a geographic breakdown of the Companys sales by shipping destination
for the following periods (in thousands):



|              |  |                             |       |                           |   |       |  |            |       |  |   |       
|------------- |  | --------------------------- | ----- | ------------------------- | - | ----- |  | ---------- | ----- |  | - | ------
|              |  | Three Months Ended June 30, |       | Nine Months EndedJune 30,
|              |  | 2005                        |       | 2004                      |   | 2005  |  | 2004      
|              |  |                             |       | (Restated)                |   |       |  | (Restated)
|Europe        |  | $                           | 366   |                           | $ | 430   |  | $          | 1,124 |  | $ | 988   
|Korea         |  |                             |      |                           |   |      |  |            | 275   |  |   |      
|United States |  |                             | 47    |                           |   | 263   |  |            | 366   |  |   | 1,015 
|Japan         |  |                             | 1,402 |                           |   | 876   |  |            | 3,727 |  |   | 4,913 
|Taiwan        |  |                             | 458   |                           |   | 73    |  |            | 617   |  |   | 578   
|China         |  |                             | 270   |                           |   | 851   |  |            | 694   |  |   | 992   
|Hong Kong     |  |                             | 14    |                           |   |      |  |            | 284   |  |   | 1,365 
|Rest of World |  |                             | 329   |                           |   | 108   |  |            | 200   |  |   | 149   
|              |  |                             |       |                           |   |       |  |            |       |  |   |       
|              |  | $                           | 2,886 |                           | $ | 2,601 |  | $          | 7,287 |  | $ | 10,000
|              |  |                             |       |                           |   |       |  |            |       |  |   |       





11



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



Approximately 98% of the Companys total revenue for the three months ended June 30, 2005 was derived from sales
to end customers based outside the United States versus 90% for the three months ended June 30, 2004.



13. Commitments and contingencies



Lease commitments: The Company leases office space and equipment under non-cancelable operating leases. The Company also has a capital lease for research and development
related software and a capital lease for manufacturing test equipment.



The
Companys total commitments on its operating and capital leases and inventory purchases as of June 30, 2005, were as follows (in thousands):



|                                                   |  |                  |       |               |   |      |                                |  |   |      
|-------------------------------------------------- |  | ---------------- | ----- | ------------- | - | ---- | ------------------------------ |  | - | -----
|Year ending September 30,                          |  | Operating Leases |       | CapitalLeases |   |      | Inventory Purchase Commitments
|2005                                               |  | $                | 282   |               | $ | 157  |                                |  | $ | 3,374
|2006                                               |  |                  | 1,036 |               |   | 86   |                                |  |   |     
|2007                                               |  |                  | 536   |               |   | 21   |                                |  |   |     
|                                                   |  |                  |       |               |   |      |                                |  |   |      
|Total minimum lease payments                       |  | $                | 1,854 |               |   | 264  |                                |  | $ | 3,374
|                                                   |  |                  |       |               |   |      |                                |  |   |      
|Less: amount representing interest                 |  |                  |       |               |   | (14  | )                              |  |   |      
|                                                   |  |                  |       |               |   |      |                                |  |   |      
|Present value of minimum lease payments            |  |                  |       |               |   | 250  |                                |  |   |      
|Less: current portion of capital lease obligations |  |                  |       |               |   | (207 | )                              |  |   |      
|                                                   |  |                  |       |               |   |      |                                |  |   |      
|Long-term capital lease obligations                |  |                  |       |               | $ | 43   |                                |  |   |      
|                                                   |  |                  |       |               |   |      |                                |  |   |      



Contingencies: From time to time, in
the normal course of business, various claims could be made against the Company, its directors or officers. The Company has agreed to indemnify its officers and directors with respect to such claims, except in limited circumstances. At March 31,
2005, the Company had no liabilities recorded for such claims as the Company is unable to estimate the liabilities at this time. For more information regarding the Companys indemnification obligations and pending litigation, please see Notes
13 and 15 below.



14. Guarantees



In November 2002, the FASB issued FIN No. 45 Guarantors Accounting and
Disclosure Requirements for Guarantees, including Indirect Guarantees of Indebtedness of Othersan interpretation of FASB Statements No. 5, 57 and 107 and rescission of FIN 34. The following is a summary of the Companys agreements
that the Company has determined are within the scope of FIN 45.



The Company
provides a limited warranty for up to one year for any defective products. During the quarter ended March 31, 2005 and for the transition period ended September 30, 2004, warranty expense was insignificant. The Company has a reserve for warranty
costs of $30,000, which has not changed in the past quarter.



In March 2004,
the Company entered into a Security Agreement to provide collateral for outstanding standby letters of credit which totaled $0.7 million at December 31, 2004. In March 2005, one of these standby letters of credit expired. The remaining outstanding
standby letter of credit totals approximately $0.2 million.



12



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



Pursuant to its bylaws, the Company has agreed to indemnify its officers and directors for certain events or
occurrences arising as a result of the officer or director serving in such capacity. The term of the indemnification period is for the officers or directors lifetime. The Company is likely to incur costs in connection with these
indemnification agreements as a result of the recent litigation. However, the Company has no liabilities recorded for these agreements as of March 31, 2005 as the Company is unable to estimate these liabilities at this time. During the quarter ended
December 31, 2004 the Company obtained a new Directors and Officers (D&O) Liability Insurance policy. However, this new D&O policy does not cover the lawsuits described in Note 15 although the claims involved in these lawsuits
may be covered by the aforementioned indemnification agreements.



The Company
enters into indemnification provisions under (i) its agreements with other companies in its ordinary course of business, typically with business partners, contractors and customers, its sublandlord and (ii) its agreements with investors. Under these
provisions the Company has agreed to generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of the Companys activities or, in some cases, as a result of the indemnified
partys activities under the agreement. These indemnification provisions often include indemnifications relating to representations made by the Company with regard to intellectual property rights. These indemnification provisions generally
survive termination of the underlying agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification provisions is unlimited. To date, the Company has not incurred any costs in connection
with these indemnification agreements. Accordingly, the Company has no liabilities recorded for these agreements as of June 30, 2005.



15. Recent Accounting Pronouncements



In November 2004, the FASB issued SFAS No. 151, Inventory Costsan amendment of ARB No. 43, Chapter 4. (SFAS 151). SFAS 151 amends ARB 43,
Chapter 4 to clarify that abnormal amounts of idle freight, handling costs and spoilage should be recognized as current period charges. SFAS 151 is effective for inventory costs incurred during fiscal years beginning after June 15, 2005.
The Company does not anticipate that the adoption of this standard will have a material impact on the Companys consolidated financial statements.



In December 2004, the FASB issued SFAS No. 152 Accounting for Real Estate Time-Sharing Transactionsan amendment of FASB statements No. 66 and 67
(SFAS 152). SFAS 152 amends SFAS 66 and 67 to reference the financial accounting and reporting guidance for real estate time-sharing transactions that is provided in AICPA Statement of Position (SOP) 04-2, Accounting for Real Estate
Time-Sharing Transactions. SFAS 152 is effective for financial statement for fiscal years beginning after June 15, 2005. The Company does not anticipate that the adoption of this standard will have a material impact on the Companys
consolidated financial statements.



In December 2004, the FASB issued SFAS No.
153 Exchanges of Non-monetary Assetsan amendment of APB opinion No. 29 (SFAS 153). SFAS 153 clarifies that exchanges of non-monetary assets should be measured based on the fair value of the assets exchanged, with a
general exception for exchanges that have no commercial substance. SFAS 153 is effective for non-monetary asset exchanges occurring in fiscal periods beginning after June 15, 2005. The Company does not anticipate that the adoption of this standard
will have a material impact on the Companys consolidated financial statements.



In December 2004, the FASB revised SFAS No. 123 (SFAS 123 (R)). SFAS 123 (R), Share-Based Payment, requires all share-based payments to employees, including grants of employee stock options, to be recognized in the
financial statements based on their fair values. Pro forma disclosure is no longer an alternative



13



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



to financial statement recognition. SFAS 123 (R) is effective for periods beginning after June 15, 2005. On April 14, 2005, the SEC announced the adoption of
a new rule that amended the compliance dates for SFAS 123 (R). Under the new rule, companies are allowed to implement SFAS 123 (R) at the beginning of the next fiscal year, instead of the next reporting period, that begins after June 15, 2005. The
Company is required to comply with SFAS 123 (R) beginning with the Companys fiscal quarter ending December 31, 2005. SFAS 123 (R) provides transition alternatives for public companies to restate prior interim periods or prior years. The
Company is still evaluating the transition provisions allowed by SFAS 123 (R).



In March 2005, the SEC released SEC Staff Accounting Bulletin No. 107, Share-Based Payment (SAB 107). SAB 107 provides the SEC staffs position regarding the application of SFAS 123 (R) and certain SEC rules and
regulations, and also provides the staffs views regarding the valuation of share-based payment arrangements for public companies. The Company is currently reviewing the effect, if any, that the application of SAB 107 will have on the
Companys financial position and results of operations.



In March 2005,
the FASB issued FASB Interpretation No. 47, Accounting for Conditional Asset Retirement Obligations (FIN 47), which clarifies the term conditional asset retirement obligations as used in SFAS No. 143,
Accounting for Asset Retirement Obligations. The Company does not anticipate that the application of FIN 47 will have a material impact on the Companys financial position and results of operations.



In May 2005, the FASB issued SFAS No. 154 Accounting Changes and Error Corrections
 a replacement of APB Opinion No. 20, and FASB Statement No. 3. (SFAS 154). SFAS 154 replaces APB Opinion No. 20, Accounting Changes, and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial Statements, and
changes the requirements for the accounting for and reporting of a change in accounting principle. This statement applies to all voluntary changes in accounting principle. It also applies to changes required by an accounting pronouncement in the
unusual instance that the pronouncement does not include specific transition provisions. When a pronouncement includes specific transition provisions, those provisions should be followed. SFAS 154 is effective for accounting changes and corrections
of errors made in fiscal years beginning after December 31, 2005. The Company does not anticipate that the adoption of this standard will have a material impact on the Companys consolidated financial statements.



16. Litigation



The Company is a party to lawsuits in the normal course of its business. Litigation in
general, and securities litigation in particular, can be expensive and disruptive to normal business operations. Moreover, the results of legal proceedings are difficult to predict. In addition, given the Companys financial condition and that
the Company does not have insurance to offset the cost of litigation, the costs of defending one or more of these lawsuits will likely adversely affect the Companys financial condition. The Company has no liabilities recorded for pending
lawsuits as the Company is unable to estimate these liabilities at this time. The Company accrues legal costs when incurred.



SEC Investigation



On or about November 9, 2004, the U.S. Securities and Exchange Commission (the SEC) requested that the Company voluntarily produce documents responsive to
certain document requests in the investigation entitledIn the Matter of Tripath Technology, Inc. On or about January 25, 2004, February 14, 2005, and February 16, 2005, the SEC made additional documents requests. On or about March 30, 2005,
the SEC issued a subpoena to the Company seeking additional documents. The Company has produced documents in response to the SECs voluntary requests for documents as well as the subpoena. The Company has cooperated with the SEC in its review
of these matters.



On or about February 24, 2005, the SEC, pursuant to Section
20(a) of the Securities Act and Section 21(a) of the Exchange Act, issued a formal order of private investigation to determine whether there have been any violations of Section 17(a) of the Securities Act and Sections 10(b), 13(a), 13(b)(2)(A),
13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 10b-5, 12b-20, 13a-13, 13a-14, 13b2-1 and 13b2-2 thereunder.



14



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



Federal Securities Class Actions



Beginning on November 4, 2004, plaintiffs filed four separate complaints purporting to be
class actions in the United States District Court for the Northern District of California alleging that the Company and certain of its officers and/or directors violated Sections 10(b) and 20(a) of the Exchange Act. Plaintiffs purport to represent a
putative class of shareholders who purchased or otherwise acquired Tripath securities between January 29, 2004 and October 22, 2004. The complaints contain varying allegations, including that the Company and the individual defendants made materially
false and misleading statements with respect to its financial results and with respect to the Companys business, prospects and operations in its filings with the SEC, press releases and other disclosures. The complaints seek unspecified
compensatory damages, attorneys fees, expert witness fees, costs and such other relief as may be awarded by the Court.



On December 22, 2004, the Court entered a stipulation and order consolidating all of these complaints and ordering that the defendants need not respond to any of these
complaints until after plaintiffs file a consolidated complaint. On January 4, 2005, plaintiffs filed motions for the appointment of lead plaintiff. The Court, by Order dated January 28, 2005, appointed Robert Poteet as the sole lead plaintiff and
approved Milberg Weiss Bershad & Schulman LLP as lead counsel.



On July 11,
2005, the Company entered into a Stipulation and Settlement Agreement (the Stipulation) which was filed with the Court on July 12, 2005. The settlement class consists of all persons who purchased the securities of Tripath between January
29, 2004 and June 13, 2005, inclusive. Under the terms of the Stipulation, the parties agreed that the class action will be dismissed in exchange for a payment of $200,000 in cash by Tripath and the issuance of 2.45 million shares of Tripath common
stock which shall be exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933. The Stipulation remains subject to the satisfaction of various conditions, including without limitation (1) final approval of the Stipulation
by the Court, including a finding that the 2.45 million shares of Tripath common stock to be issued are exempt from registration pursuant to Section 3(a)(1) of the Securities Act of 1933 and (2) notification to members of the settlement class in the
Class Action.



Derivative Shareholder Litigation



On December 7, 2004, plaintiff Mildred Lyon filed a purported derivative
action in Santa Clara Superior Court against the Company and certain of its officers and/or directors. This complaint appears to be based upon the same facts and circumstances as the federal class actions and makes the following claims: violation of
Section 25402 of the California Corporations Code, breach of fiduciary duty and misappropriation of information, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. On this basis, the complaint seeks unspecified
compensatory damages, treble damages under Section 25502.5(a) of the California Corporations Code, extraordinary equitable and/or injunctive relief, restitution and disgorgement, attorneys fees, expert witness fees, costs, and such other
relief as may be ordered by the Court.



On December 27, 2004, the Court entered
a stipulation and order extending the time for the Company to respond to the complaint to February 23, 2005. On February 16, 2005, the Court entered an order further extending the time for the Company to respond to the complaint to March 25, 2005.
On March 10, the Court ordered that the individual defendants shall have through and including April 25, 2005 to file any motions to quash and/or dismiss for lack of personal jurisdiction, and that all defendants shall have thirty (30) days from the
date the court issues a ruling on any motions to quash and/or dismiss for lack of personal jurisdiction to respond to the complaint, or in the event that no such motions are brought, extended the time for all defendants to respond to the complaint
to April 25, 2005.





15



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



On April 4, 2005, the Court ordered that all deadlines shall be stayed for Defendants filing any motions to quash
and/or dismiss for lack of personal jurisdictions, or otherwise respond to the Complaint, until such date as the parties mutually designate to the Court for the Courts approval. A Case Management Conference is scheduled for August 16, 2005
before the Court. The parties currently are engaged in settlement discussions.



Langley Securities Fraud Litigation



On
or about June 2, 2005, plaintiff Langley Partners, L.P. (Langley) filed a complaint in the United States District Court for the Southern District of New York alleging claims against the Company, Dr. Adya Tripathi, the Companys
President and Chief Executive Officer, and David Eichler, the Companys former Chief Financial Officer. Langley alleges that it entered into a stock purchase agreement with Tripath on or about August 2, 2004 in which Langley purchased 1 million
shares of Tripath common stock at a purchase price of $2.00 per share. Langley also alleges that it consented to the receipt of the Companys Prospectus dated August 2, 2004 and the accompanying Prospectus dated June 1, 2004 which specifically
incorporated certain of the Companys filings with the SEC from March through July 2004. The complaint generally alleges that the Company and the individual defendants made materially false and misleading statements with respect to the
Companys financial results and with respect to its business, prospects, internal accounting controls and design wins on Godzilla products in the Companys filings with the SEC, press releases and other documents. The complaint alleges
claims against the Company and the individual defendants for violations of Sections 10(b) and 20(a) of the Exchange Act, fraud, breach of contract, unjust enrichment and money had and received, rescission and violations of Sections 11 and 15 of the
Securities Act. On this basis, the complaint seeks unspecified compensatory damages and restitution in an amount in excess of $2 million, rescission of the purchase agreement and a return of $2 million, unspecified punitive damages, costs and such
other relief as may be awarded by the Court.



On July 12, 2005, the Company
served a motion to transfer this action from the Southern District of New York to the United States District Court for the Northern District of California on plaintiff. The Company filed this motion with the Court on July 20, 2005. This motion has
not yet been fully briefed. On June 29, 2005, the Court entered a stipulation and order extending the time for all defendants to respond to the complaint until August 2, 2005. On July 28, 2005, the Court entered a further stipulation and proposed
order extending the time for all defendants to respond to the complaint until 14 days after the Courts ruling on the motion to transfer or 40 days after all briefing on the motion to transfer is filed, whichever is earlier. A Pre-Trial
Conference is scheduled before the Court on August 25, 2005. The Company has not yet responded to the complaint.



Changes in and Disagreements with Accountants



As previously disclosed in the Companys current report on Form 8-K dated October 18, 2004 and filed on October 22, 2004, in October 2004, the Companys former
independent registered public accountants, BDO Seidman LLP (BDO), provided the Companys Audit Committee with a letter citing what BDO asserted are two material weaknesses over the Companys internal financial
controls: one regarding the lack of effectiveness of the Companys Audit Committee and the other regarding the lack of controls in place to estimate distributor returns in accordance with SFAS No. 48. Following discussions with employees of the
Company, representatives of BDO further orally advised the Company that BDO had concerns regarding the appropriate accounting for approximately $1.3 million of product that, upon the Companys inquiries, one of the Companys distributors,
Macnica (the Distributor), reported had been returned to the Distributor by the Distributors customers (the Product Return). In response to both the letter and the verbal comments, the Audit Committee instructed the
Companys Chief Financial Officer to investigate this matter and report the findings to the Audit Committee. As a result of the litigation matters referenced above, the Company retained outside litigation counsel to represent the Company in
responding to the aforementioned complaints. In addition, the Audit



16



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



Committee and the Chief Financial Officer directed litigation counsel to further conduct an internal investigation into the verbal concerns raised by BDO
regarding the Product Return. Separately, the Audit Committee, with the assistance of the Companys Chief Financial Officer investigated BDOs assertion regarding the lack of controls in place to estimate distributor returns.



The Audit Committee received an initial report from the Companys litigation counsel
on findings of the internal investigation on January 21, 2005 and requested additional investigation by litigation counsel. On January 25, 2005, litigation counsel made a supplemental report on the findings of the internal investigation to date.
Following the presentation of such report, including discussion of the findings of the forensic accountant hired by the litigation counsel with the approval of the Audit Committee, the Audit Committee concluded that the Companys Country
Manager for the Japan Sales Office (who is no longer employed with the Company) agreed in an arrangement outside the formal paperwork of the transactions underlying the Product Return that the Distributor could return the products back to the
Company at the Distributors discretion.



The Audit Committee
investigation and discussion included a review of the Companys compliance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 Revenue Recognition in Financial Statements (SAB 104) as applied to the
circumstances surrounding the Product Return. Under SAB 104, a requirement for revenue recognition is that all of the following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery of goods has occurred,
(3) the sales price is fixed or determinable, and (4) collectibility is reasonably assured. In addition, pursuant to the Companys revenue recognition policy, for sales to distributors, the Company defers recognition of revenue until such time
that the distributor sells products to its customers based upon receipt of point-of-sales reports from the Distributor. The internal investigation revealed that approximately $1.4 million of a sale of the Companys product to the Distributor
did not meet the foregoing criteria because a former employee of the Company had agreed that the Distributor could return the product at the Distributors discretion, which forms the basis of the Restatement. This former employee had on this
occasion agreed to a term of sale that was outside of the Companys standard practices and was not referenced in the documentation related to the sale submitted to the Companys finance department. Given the discovery of this arrangement
for the Distributor to return the product, the Audit Committee concluded on January 25, 2005 that the Company should restate certain financial information that was previously reported in the Companys Form 10-Q for the quarter ended June 30,
2004 filed with the Securities and Exchange Commission on August 6, 2004 (the Restatement). For more information regarding the Restatement, please see Note 9 to the Companys consolidated financial statements, Supplementary
Financial Information in the Companys Transitional Report on Form 10-K/T filed with the Securities and Exchange Commission on February 3, 2005. In addition, the Audit Committee approved certain changes to the Companys internal
controls over financial reporting as an additional remedial action in response to the report of the litigation counsel and its forensic accountant and to the report by the Companys Chief Financial Officer. For more information regarding these
changes, please see Item 9A, Controls and Procedures.



17. Restatement of Previously Reported Quarterly and Transition Period Financial Information



As originally described in the Companys Current Report on Form 8-K dated October 18, 2004 and filed with the Securities and Exchange Commission on October 22, 2004 (the Prior 8-K), the Companys
Audit Committee initiated an internal investigation regarding certain purported product returns (the Product Returns) to one of the Companys distributors, Macnica Japan (Macnica), by its customers. The Audit Committee
investigation and discussion included a review of the Companys compliance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 Revenue Recognition in Financial Statements (SAB 104) as applied to the
circumstances surrounding the Product Returns. Under SAB 104, a requirement for revenue recognition is that all of the following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery of goods has occurred,
(3) the sales price is fixed or determinable, and (4) collectibility is reasonably



17



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



assured. In accordance with SAB 104, the Companys revenue recognition policy, for sales to distributors, requires that the Company defer recognition of
revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sales reports from the distributor. As of the Audit Committees determination on January 25, 2005, the internal investigation revealed
that approximately $1.4 million of a sale of the Companys product to Macnica did not meet the foregoing criteria because the Companys Country Manager for the Japan Sales Office (who is no longer employed by the Company) had agreed that
Macnica could return the product to the Company at Macnicas discretion. The Audit Committee determined that this former employee had agreed to a term of sale that was outside of the Companys standard practices and was not referenced in
the documentation related to the sale submitted to the Companys finance department. Given the discovery of this arrangement for Macnica to return the product, the Companys Audit Committee concluded that the Company should restate certain
financial information that was previously reported in the Companys Form 10-Q for the quarter ended June 30, 2004, filed with the Securities and Exchange Commission on August 6, 2004 (the June 2004 Form 10-Q) to properly reflect its
revenue and related financial information for the referenced periods (the Initial Restatement). Accordingly, the Company advised in the Prior 8-K that the Consolidated Statement of Operations for the three months and six months ended
June 30, 2004 and the Consolidated Balance Sheet as of June 30, 2004 included in the June 2004 Form 10-Q should no longer be relied upon because of errors in such financial statements. The financial impact of the Initial Restatement was reflected in
the Companys Transition Report on Form 10-K/T for the transition period ended September 30, 2004 filed with the Securities and Exchange Commission on February 3, 2005 (the Transition Report).



The Audit Committee directed that the internal investigation continue following reporting of
the Initial Restatement. As a result of this further investigation, on May 5, 2005 the Audit Committee determined that additional sale transactions with Macnica, as well as with an additional distributor of the Company, Uniquest, did not meet the
Companys revenue recognition criteria and the requirements of SAB 104. In certain circumstances, the same former employee of the Company had agreed that Macnica could return the referenced product at Macnicas discretion. This former
employee had on these occasions agreed to a term of sale that was outside of the Companys standard practices and was not referenced in the documentation related to the sale submitted to the Companys finance department. In addition, the
Audit Committee determined that, in certain other circumstances, Macnica had shipped product not to end customers but to other distributors and the Company had relied on point-of-sales reports submitted to the Company by Macnica that indicated the
referenced product had been shipped to an end customer of Macnica when such product had only been shipped to other distributors. Recognition of revenue on sales between distributors instead of to the end customers is not permitted under the
Companys revenue recognition policies. Further, the Audit Committee determined that certain sales transactions with Uniquest did not meet the Companys revenue recognition criteria and the requirements of SAB 104 because in certain
circumstances, employees of Uniquest had incorrectly reported to the Company the date of shipments to end customers.



As a result, the Audit Committee concluded on May 5, 2005 that the Company should restate certain financial information (the Additional Restatement) that was
previously reported in the Companys Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004 and December 31, 2004 as well as certain financial information for the quarter and transitional period ended
September 30, 2004 that was previously reported in the Companys Transition Report. The Additional Restatement was based on the Audit Committees conclusion on such date that the Consolidated Balance Sheets as of March 31, 2004, June 30,
2004, September 30, 2004 and December 31, 2004 and the related Consolidated Statements of Operations for the three months ended March 31, 2004, the three and six months ended June 30, 2004, the nine month transition period ended September 30, 2004
and the three months ended December 31, 2004 should no longer be relied upon because of errors in such financial statements. The Additional Restatement was originally described in our Current Report on Form 8-K dated May 5, 2005 and filed with the
Securities and Exchange Commission on May 11, 2005.



18



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



Following receipt of a final report on the internal investigation, the Audit Committee determined that the internal
investigation had been completed on June 15, 2005. The internal investigation revealed errors in the Companys financial statements for 2002 and 2003. Such errors included certain shipments between distributors rather than to end-customers
which was not noted on applicable point-of-sales reports, inaccurate shipment dates on certain point-of-sales reports, and inaccurate quantities noted on certain point-of-sales reports. The Company reviewed these errors with reference to the
guidelines set forth in SAB99. Based upon such review, the Company concluded that such errors were immaterial and thus would not result in a restatement of the 2002 or 2003 financial statements.



The following table provides a reconciliation of amounts previously reported in the
Companys Form 10-Q for the quarter ended June 30, 2004 with amounts previously adjusted for the restatement as a result of the Audit Committees investigation.



CONSOLIDATED STATEMENT OF OPERATIONS

(unaudited)

(in thousands, except per share data)



|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|--------------------------------------------------------------------- |  | -------------------------------- | ------ | - | -------------------------------- | - | ------ | ------------------------------- |  | - | ------ | - |  | - | ---- | - |  | - | ------ | -
|                                                                      |  | Three Months Ended June 30, 2004 |        |   | AdditionalRestatement Adjustment |   |        | Restated Total                  | 
|                                                                      |  | PreviouslyReported               |        |   | InitialRestatementAdjustment     |   |        | RestatedTotalPreviouslyReported |  |   |       
|Revenue                                                               |  | $                                | 4,407  |   |                                  | $ | (1,370 | )                               |  | $ | 3,037  |   |  | $ | (436 | ) |  | $ | 2,601  |  
|Cost of revenue                                                       |  |                                  | 3,222  |   |                                  |   | (607   | )                               |  |   | 2,615  |   |  |   | (281 | ) |  |   | 2,334  |  
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Gross profit (loss)                                                   |  |                                  | 1,185  |   |                                  |   | 763    |                                 |  |   | 422    |   |  |   | (155 | ) |  |   | 267    |  
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Operating expenses:                                                   |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Research and development                                              |  |                                  | 1,876  |   |                                  |   |       |                                 |  |   | 1,876  |   |  |   |     |   |  |   | 1,876  |  
|Selling, general and administrative                                   |  |                                  | 1,154  |   |                                  |   |       |                                 |  |   | 1,154  |   |  |   |     |   |  |   | 1,154  |  
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Total operating expenses                                              |  |                                  | 3,030  |   |                                  |   |       |                                 |  |   | 3,030  |   |  |   |     |   |  |   | 3,030  |  
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Loss from operations                                                  |  |                                  | (1,845 | ) |                                  |   | 763    |                                 |  |   | (2,608 | ) |  |   | (155 | ) |  |   | (2,763 | )
|Interest and other income (expense), net                              |  |                                  | (40    | ) |                                  |   |       |                                 |  |   | (40    | ) |  |   |     |   |  |   | (40    | )
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Net loss                                                              |  | $                                | (1,885 | ) |                                  | $ | 763    |                                 |  | $ | (2,648 | ) |  | $ | (155 | ) |  | $ | (2,803 | )
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Basic and diluted net loss per share                                  |  | $                                | (0.04  | ) |                                  |   |        |                                 |  | $ | (0.06  | ) |  |   |      |   |  | $ | (0.06  | )
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  
|Number of shares used to compute basic and diluted net loss per share |  |                                  | 45,878 |   |                                  |   |        |                                 |  |   | 45,878 |   |  |   |      |   |  |   | 45,878 |  
|                                                                      |  |                                  |        |   |                                  |   |        |                                 |  |   |        |   |  |   |      |   |  |   |        |  





19



---

##### Table of Contents

Tripath Technology Inc.



Notes to Condensed Interim Consolidated Financial Statements(Continued)

(Unaudited)



CONSOLIDATED BALANCE SHEET

(in thousands)



The
following table provides a reconciliation of amounts previously reported in the Companys Transitional Report on Form 10-K/T for the nine months ended September 30, 2004 with amounts previously adjusted for the restatement as a result of the
Audit Committees Investigation.



|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|-------------------------------------------- |  | ---------------------- | -------- | - | --------------------- | - | --- | ------------- |  | - | -------- | -
|                                             |  | September 30, 2004     |         
|                                             |  | PreviouslyReported (1) |          |   | RestatementAdjustment |   |     | RestatedTotal | 
|ASSETS                                       |  |                        |          |   |                       |   |     |               |  |   |          |  
|Current assets:                              |  |                        |          |   |                       |   |     |               |  |   |          |  
|Cash, cash equivalents and restricted cash   |  | $                      | 7,339    |   |                       | $ |    |               |  | $ | 7,339    |  
|Accounts receivable, net                     |  |                        | 1,019    |   |                       |   |    |               |  |   | 1,019    |  
|Inventories, net                             |  |                        | 3,780    |   |                       |   | 159 | (3)           |  |   | 3,939    |  
|Prepaid expenses and other current assets    |  |                        | 212      |   |                       |   |    |               |  |   | 212      |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Total current assets                         |  |                        | 12,350   |   |                       |   | 159 |               |  |   | 12,509   |  
|Property and equipment, net                  |  |                        | 1,674    |   |                       |   |    |               |  |   | 1,674    |  
|Other assets                                 |  |                        | 123      |   |                       |   |    |               |  |   | 123      |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Total assets                                 |  | $                      | 14,147   |   |                       | $ | 159 |               |  | $ | 14,306   |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|LIABILITIES AND STOCKHOLDERS EQUITY         |  |                        |          |   |                       |   |     |               |  |   |          |  
|Current liabilities:                         |  |                        |          |   |                       |   |     |               |  |   |          |  
|Accounts payable                             |  | $                      | 2,908    |   |                       | $ |    |               |  | $ | 2,908    |  
|Current portion of capital lease obligations |  |                        | 664      |   |                       |   |    |               |  |   | 664      |  
|Current portion of deferred rent             |  |                        | 266      |   |                       |   |    |               |  |   | 266      |  
|Accrued expenses                             |  |                        | 764      |   |                       |   |    |               |  |   | 764      |  
|Deferred distributor revenue                 |  |                        | 823      |   |                       |   | 252 | (2)           |  |   | 1,075    |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Total current liabilities                    |  |                        | 5,425    |   |                       |   | 252 |               |  |   | 5,677    |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Long term liabilities:                       |  |                        | 471      |   |                       |   |    |               |  |   | 571      |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Stockholders equity:                        |  |                        |          |   |                       |   |     |               |  |   |          |  
|Common stock                                 |  |                        | 49       |   |                       |   |    |               |  |   | 49       |  
|Additional paid-in capital                   |  |                        | 199,333  |   |                       |   |    |               |  |   | 199,333  |  
|Deferred stock-based compensation            |  |                        | (95      | ) |                       |   |    |               |  |   | (95      | )
|Accumulated deficit                          |  |                        | (191,136 | ) |                       |   | (93 | )             |  |   | (191,229 | )
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Total stockholders equity                   |  |                        | 8,151    |   |                       |   | (93 | )             |  |   | 8,058    |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  
|Total liabilities and stockholders equity   |  | $                      | 14,147   |   |                       | $ | 159 |               |  | $ | 14,306   |  
|                                             |  |                        |          |   |                       |   |     |               |  |   |          |  

---

|(1) | As previously reported in the Companys Transitional Report on Form 10-K/T for the nine months ended September 30, 2004.
|--- | ------------------------------------------------------------------------------------------------------------------------

|(2) | Reflects the deferral of revenue of approximately $252,000 relating to product shipped not to end customers but to other distributors.
|--- | --------------------------------------------------------------------------------------------------------------------------------------

|(3) | Reflects an increase in inventory of $159,000 relating to the deferred cost associated with the deferred revenue.
|--- | -----------------------------------------------------------------------------------------------------------------



20



---

##### Table of Contents

18. Subsequent Event



On August 4, 2005 the Company entered into a credit agreement with a financial institution for a one-year credit facility. The agreement
provides advances against up to $6 million of eligible receivables at a 60% advance rate, such that the aggregate principal amount of the advances outstanding at any time may not exceed $3.6 million. Borrowings under the agreement are secured by the
Companys personal and intellectual property and will bear interest at 12% per annum. The credit agreement contains a covenant that requires an infusion of subordinated debt or equity into the Company in an amount no less than $4 million on or
before March 1, 2006 and an additional $3 million on or before June 1, 2006. The Company has not drawn down any amount from the available credit facility.



Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.



This report contains forward looking statements (as such term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934) and information relating to us that are based on the beliefs of our management as well as assumptions made by and information currently available to our management. In addition, when used in this report, the words likely,
will, suggests, target, may, would, could, anticipate, believe, estimate, expect, intend, plan,
predict, and similar expressions and their variants, as they relate to us or our management, may identify forward looking statements. Such statements reflect our judgment as of the date of this quarterly report on Form 10-Q with respect
to future events, the outcome of which are subject to certain known and unknown risks and uncertainties, including the factors discussed under the caption Risk Factors, and those discussed elsewhere in this quarterly report on Form 10-Q,
which may have a significant impact on our business, operating results or financial condition. Investors are cautioned that these forward looking statements are inherently uncertain. Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual results or outcomes may vary materially from those described herein. Although we believe that the expectations reflected in these forward looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance or achievements. All forward looking statements included in this report are based on information available to us as of the date of this report. We undertake no obligation to update or revise any
forward looking statements, whether as a result of new information, future events or otherwise, unless we are required to do so by law.



The following discussion and analysis should be read in connection with the condensed consolidated financial statements and the notes thereto included in Item 1 in this
quarterly report and our transition report on Form 10-K/T for the transition period ended September 30, 2004.



Restatement



As originally described in
our Current Report on Form 8-K dated October 18, 2004 and filed with the Securities and Exchange Commission on October 22, 2004 (the Prior 8-K), our Audit Committee initiated an internal investigation regarding certain purported product
returns (the Product Returns) to one of our distributors, Macnica Japan (Macnica), by its customers. The Audit Committee investigation and discussion included a review of our compliance with Securities and Exchange Commission
Staff Accounting Bulletin No. 104 Revenue Recognition in Financial Statements (SAB 104) as applied to the circumstances surrounding the Product Returns. Under SAB 104, a requirement for revenue recognition is that all of the
following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery of goods has occurred, (3) the sales price is fixed or determinable, and (4) collectibility is reasonably assured. In addition to SAB 104, our
revenue recognition policy, for sales to distributors, requires that we defer recognition of revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sales reports from the distributor. As of the
Audit Committees determination on January 25, 2005, the internal investigation revealed that approximately $1.4 million of a sale of our product to Macnica did not meet the foregoing criteria because our Country Manager for the Japan Sales
Office (who is no longer employed by us) had agreed that Macnica could return the product to us at Macnicas discretion. The Audit Committee determined that this former employee had agreed to a term of sale that was outside of our standard
practices and was not referenced in the documentation related to the sale submitted to our finance department. Given the discovery of this arrangement for Macnica to return the product, our Audit Committee concluded that we should restate certain
financial information that was previously reported in our Form 10-Q for the quarter ended June 30, 2004, filed with the Securities and Exchange Commission on August 6, 2004 (the June 2004 Form 10-Q) to properly reflect our revenue and
related financial information for the referenced periods (the Initial Restatement). Accordingly, we advised in the Prior 8-K that the Consolidated Statement of Operations for the three months and six months ended June 30, 2004 and the
Consolidated Balance Sheet as of June 30, 2004 included in the June 2004 Form 10-Q should no longer be relied upon because of errors in such financial statements. The financial impact of the Initial Restatement was reflected in our Transition Report
on Form 10-K/T for the transition period ended September 30, 2004 filed with the Securities and Exchange Commission on February 3, 2005 (the Transition Report).



21



---

##### Table of Contents

The Audit Committee directed that the internal investigation continue following reporting of the Initial Restatement. As
a result of this further investigation, on May 5, 2005 the Audit Committee determined that additional sale transactions with Macnica, as well as with an additional distributor of the Company, Uniquest, did not meet the our revenue recognition
criteria and the requirements of SAB 104. In certain circumstances, the same former employee of the Company had agreed that Macnica could return the referenced product at Macnicas discretion. This former employee had on these occasions agreed
to a term of sale that was outside of our standard practices and was not referenced in the documentation related to the sale submitted to our finance department. In addition, the Audit Committee determined that, in certain other circumstances,
Macnica had shipped product not to end customers but to other distributors and we had relied on point-of-sales reports submitted to us by Macnica that indicated the referenced product had been shipped to an end customer of Macnica when such product
had only been shipped to other distributors. Recognition of revenue on sales between distributors instead of to the end customers is not permitted under our revenue recognition policies. Further, the Audit Committee determined that certain sales
transactions with Uniquest did not meet our revenue recognition criteria and the requirements of SAB 104 because in certain circumstances, employees of Uniquest had incorrectly reported to us the date of shipments to end customers.



As a result, the Audit Committee concluded on May 5, 2005 that we should restate certain
financial information (the Additional Restatement) that was previously reported in our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004 and December 31, 2004 as well as certain financial
information for the quarter and transitional period ended September 30, 2004 and that was previously reported in our Transitional Report. The Additional Restatement was based on the Audit Committees conclusion on such date that the
Consolidated Balance Sheets as of March 31, 2004, June 30, 2004, September 30, 2004 and December 31, 2004 and the related Consolidated Statements of Operations for the three months ended March 31, 2004, the three and six months ended June 30, 2004,
the nine month transition period ended September 30, 2004 and the three months ended December 31, 2004 should no longer be relied upon because of errors in such financial statements. The Additional Restatement was originally described in our Current
Report on Form 8-K dated May 5, 2005 and filed with the Securities and Exchange Commission on May 11, 2005.



Following receipt of a final report on the internal investigation, the Audit Committee determined that the internal investigation had been completed on June 15, 2005. The internal investigation revealed errors in our
financial statements for 2002 and 2003. Such errors included certain shipments between distributors rather than to end-customers which was not noted on applicable point-of-sales reports, inaccurate shipment dates on certain point-of-sales reports,
and inaccurate quantities noted on certain point-of-sales reports. We reviewed these errors with reference to the guidelines set forth in SAB99. Based upon such review, we concluded that such errors were immaterial and thus would not result in a
restatement of the 2002 or 2003 financial statements.



Critical Accounting
Policies



Use of Estimates: Managements discussion and
analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of
these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our
estimates, including those related to product returns, warranty obligations, bad debts, inventory direct costing and valuation, accruals, valuation of stock options and warrants, income taxes (including the valuation allowance for deferred taxes)
and restructuring costs. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of
assets and liabilities that are not readily apparent from the other sources. Actual results may materially differ from these estimates under different assumptions or conditions. Material differences may occur in our results of operations for any
period if we made different judgments or utilized different estimates.



22



---

##### Table of Contents

Revenue Recognition: We recognize revenue in accordance with Securities and Exchange Commission Staff Accounting
Bulletin No. 104 (SAB 104), Revenue Recognition in Financial Statements. We recognize revenue when all of the following criteria are met: 1) there is persuasive evidence that an arrangement exists, 2) delivery of goods has
occurred, 3) the sales price is fixed or determinable, and 4) collectibility is reasonably assured. The following policies apply to our major categories of revenue transactions.Sales to OEM Customers: Under our standard terms and conditions
of sale, title and risk of loss transfer to the customer at the time product is delivered to the customer, FOB shipping point, and revenue is recognized accordingly. We accrue the estimated cost of post-sale obligations, including product warranties
or returns, based on historical experience. We have experienced minimal warranty or other returns to date.Sales to Distributors: Sales to distributors are made under arrangements allowing limited rights of return, generally under product
warranty provisions, stock rotation rights and price protection on products unsold by the distributor. In addition, the distributor may request special pricing and allowances which may be granted subject to our approval. As a result of these return
rights and potential pricing adjustments, we generally defer recognition of revenue until such time that the distributor sells product to its customer based upon receipt of point-of-sale reports from the distributor.



Allowance for Doubtful Accounts: We provide an allowance for doubtful accounts to
ensure trade receivables are not overstated due to uncollectibility. The collectibility of our receivables is evaluated based on a variety of factors, including the length of time receivables are past due, indication of the customers
willingness to pay, significant one-time events and historical experience. An additional reserve for individual accounts is recorded when we become aware of a customers inability to meet its financial obligations, such as in the case of
bankruptcy filings or substantial deterioration in the customers operating results or financial position. If circumstances related to our customers change, estimates of the recoverability of receivables would be further adjusted.



Inventories: Inventories are stated at the lower of cost or market. This policy
requires us to make estimates regarding the market value of our inventory, including an assessment of excess or obsolete inventory. We determine excess and obsolete inventory based on an estimate of the future demand and estimated selling prices for
our products within a specified time horizon, generally 12 months. The estimates we use for expected demand are also used for near-term capacity planning and inventory purchasing and are consistent with our revenue forecasts. Actual demand and
market conditions may be different from those projected by our management. If our unit demand forecast is less than our current inventory levels and purchase commitments, during the specified time horizon, or if the estimated selling price is less
than our inventory value, we will be required to take additional excess inventory charges or write-downs to the net realizable value which will decrease our gross margin and net operating results in the future. During the quarter ended March 31,
2002, we recorded a provision for excess inventory of approximately $5.0 million related to excess inventory for our TA2022 product as a result of a decrease in forecasted sales for this product. In 2004, we increased the inventory reserves by an
additional $4.3 million, from $4.9 million to $9.2 million, to account for slow moving, excess, and obsolete inventory. During the quarters ended March 31, 2005 and June 30, 2005, we released net amounts of approximately $1.5 million and $1.2
million of inventory reserves respectively, which reduced inventory reserves at June 30, 2005 to $6.5 million.



Results of Operations



Three months
ended June 30, 2005 and 2004 (restated)



Revenue. Revenue for the
three months ended June 30 , 2005 was $ 2.9 million, an increase of $0.3 million or 12% from revenues of $2.6 million for the three months ended June 30, 2004. The increase in revenue resulted primarily from an increase in sales of our TA2024
product of approximately $1.2 million partially offset by a decrease in sales of our TLD4012 product of approximately $0.7 million.



23



---

##### Table of Contents

Sales to Sharp accounted for approximately 21% of revenue in the three months ended June 30, 2005 and 3% in the
corresponding prior year quarter. Sales to our five largest customers represented approximately 48% of revenue in the three months ended June 30, 2005 and 64% of revenue in the three months ended June 30, 2004.



Gross Profit. Gross profit for the three months ended June 30, 2005 was $1.6 million
or 54%, compared with a gross profit of $267,000 or 10% for the three months ended June 30, 2004. The increase in the gross profit for the three months ended June 30, 2005 reflects the sale of inventory that was previously written down to its
estimated net realizable value. This contributed $1.2 million to gross profit for the three months ended June 30, 2005. Excluding this effect, the gross profit margin would have been 11%. The lower gross margin was primarily due to lower average
selling prices.



Research and Development. Research and development
expenses for the three months ended June 30, 2005 were $1.7 million, a decrease of $0.2 million from $1.9 million for the three months ended June 30, 2004. The decrease in R&D expenses was primarily due to lower projected related expenses. We
anticipate that our R&D expenses may increase in future periods.



Selling, General and Administrative Expenses. Selling, general and administrative expenses for the three months ended June 30, 2005 were $3.9 million, an increase of approximately $2.7 million from $1.2 million for the three months
ended March 31, 2004. This increase in selling, general and administrative expenses was primarily due to a legal settlement of approximately $1.8 million, higher litigation costs of approximately $0.7 million and higher accounting fees of $125,000.
We anticipate that our S,G&A expenses will fluctuate with the amount of legal and accounting activity associated with pending litigation.



Change in fair value on revaluation of warrant liability. The change in fair value on revaluation of warrant liability represents the difference between the fair
value of the warrants on March 31, 2005 and the fair value of those same warrants on June 30, 2005.



The change in fair value on revaluation of warrant liability was $0.2 million for the three months ended June 30, 2005 compared to $0.0 for the three months ended June 30, 2004 since no warrants were issued during
that period.



Nine months ended June 30, 2005 and 2004 (restated)



Revenue. Revenue for the nine months ended June 30, 2005 was $7.3
million, a decrease of $2.7 million or 27% from revenues of $10.0 million for the nine months ended June 30, 2004. The decrease in revenue resulted primarily from a decrease in unit sales, coupled with lower average selling prices, of our TA2020 and
TLD4012 products of approximately $1.7 million and $1.0 million, respectively. Of the $7.3 million revenue for the nine months ended June 30, 2005, approximately $1.4 million was from revenue previously deferred from the transaction which resulted
in the restatement of our financial results for the quarter ended June 30, 2004. Excluding the restatement related revenues, net revenue for the nine months ended June 30, 2005 was approximately $5.9 million, a decrease of $4.1 million or 41% from
revenues of $10 million for the nine months ended June 30, 2004.



Sales to
Sharp accounted for approximately 18% of revenue in the nine months ended June 30, 2005 and 2% in the corresponding nine month period. Sales to our five largest customers represented approximately 46% of revenue in the nine months ended June 30,
2005 and 65% of revenue in the nine months ended June 30, 2004.



24



---

##### Table of Contents

Gross Profit. Gross profit for the nine months ended June 30, 2005 was $3.8 million or 52%, compared with a gross
profit of $2.5 million or 25% for the nine months ended June 30, 2004. The higher gross margin is primarily attributable to the sale of inventory that was previously written down to its estimated net realizable value. This contributed $2.7 million
to gross profit for the nine months ended June 30, 2005. Excluding this effect, the gross profit margin would have been 14% as compared to 25% for the comparable prior period. The decrease in the gross margin was primarily due to a decrease in
average selling prices.



Research and Development. Research and
development expenses for the nine months ended June 30, 2005 were $5.6 million, an increase of $0.3 million from $5.3 million for the nine months ended June 30, 2004. The increase in R&D expenses was primarily due to an increase in headcount and
related personnel costs. We anticipate that our R&D expenses may continue to increase in future periods.



Selling, General and Administrative Expenses. Selling, general and administrative expenses for the nine months ended June 30, 2005 were $7.1 million, an increase of approximately $3.6 million from $3.5 million
for the nine months ended June 30, 2004. This increase in selling, general and administrative expenses was primarily due to a legal settlement of approximately $1.8 million, higher litigation costs of approximately $1.4 million and higher accounting
fees of $327,000. We anticipate that our S,G&A expenses will fluctuate with the amount of legal and accounting activity associated with pending litigation.



Change in fair value on revaluation of warrant liability. The change in fair value on revaluation of warrant liability represents the difference between the
fair value of the warrants on the closing date, March 3, 2005, of the private placement in connection with which those warrants were issued and the fair value of those same warrants on June 30, 2005. The change in fair value on revaluation of
warrant liability was $0.5 million for the nine months ended June 30, 2005 compared to $0.0 for the nine months ended June 30, 2004 since no warrants were issued during that period.



Liquidity and Capital Resources



Since our inception, we have financed our operations through the private sale of our equity securities, primarily the sale of preferred stock, through our initial public
offering on August 1, 2000, through a private placement in January 2002, a financing in August 2004 and a private placement in March 2005. The January 2002 private placement and the March 2005 private placement included warrants whereas no warrants
were issued in connection with the August 2004 financing. Net proceeds to us as a result of our initial public offering, our 2002 private placement, our 2004 financing, and our 2005 private placement were approximately $45.4 million, $19.9 million,
$5.0 million, and $4.0 million respectively. In addition, we received $5.4 million from the exercise of warrants issued in connection with the 2002 private placement.



Net cash used in operating activities increased to $8.6 million for the nine months ended June 30, 2005 from $7.0 million for the nine
months ended June 30, 2004. The increase was mainly due to an increase in the net loss of approximately $1.2 million.



Cash used in investing activities was $48,000 for the nine months ended June 30, 2005 compared to $610,000 for the nine months ended June 30, 2004. The decrease was due
to a decrease in purchases of property and equipment.



Cash provided by
financing activities was $3.6 million for the nine months ended June 30, 2005 compared to $4.0 million for the nine months ended June 30, 2004. The positive cash flows from financing activities in 2004 and 2005 were primarily due to the proceeds
received from the sale of equity securities of the Company to investors in a registered transaction in 2004 and in a private placement in 2005, as further described below. In 2004, we received proceeds of approximately $2.3 million from the exercise
of warrants.



25



---

##### Table of Contents

In August 2004, we completed a financing in which we raised gross proceeds of $5.0 million through financing of 2,500,000
shares of common stock at a price of $2.00 per share.



In March 2005, we
completed a private placement which resulted in gross proceeds of $4.4 million. In connection with this private placement we sold 4,833,335 shares of common stock at a price of $0.90 per share and issued warrants to purchase up to 966,667 shares of
common stock.



Our total commitments on our operating and capital leases and
inventory purchases as of June 30, 2005, were as follows (in thousands):



|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      
|-------------------------------------------------- |  | ---------------- | ----- | -------------- | - | ---- | ------------------------------ |  | ------ | ----- |  | - | -----
|Year ending September 30,                          |  | Operating Leases |       | Capital Leases |   |      | Inventory Purchase Commitments |  | Totals
|2005                                               |  | $                | 282   |                | $ | 157  |                                |  | $      | 3,374 |  | $ | 3,813
|2006                                               |  |                  | 1,036 |                |   | 86   |                                |  |        |      |  |   | 1,122
|2007                                               |  |                  | 536   |                |   | 21   |                                |  |        |      |  |   | 557  
|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      
|Total minimum lease payments                       |  | $                | 1,854 |                |   | 264  |                                |  | $      | 3,374 |  | $ | 5,492
|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      
|Less: amount representing interest                 |  |                  |       |                |   | (14  | )                              |  |        |       |  |   |      
|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      
|Present value of minimum lease payments            |  |                  |       |                |   | 250  |                                |  |        |       |  |   |      
|Less: current portion of capital lease obligations |  |                  |       |                |   | (207 | )                              |  |        |       |  |   |      
|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      
|Long-term capital lease obligations                |  |                  |       |                | $ | 43   |                                |  |        |       |  |   |      
|                                                   |  |                  |       |                |   |      |                                |  |        |       |  |   |      



We expect our future liquidity and
capital requirements will fluctuate depending on numerous factors including: market acceptance and demand for current and future products, the timing of new product introductions and enhancements to existing products, the success of on-going efforts
to reduce our manufacturing costs as well as operating expenses and need for working capital for such items as inventory and accounts receivable.



We have incurred substantial losses and have experienced negative cash flow since inception and have an accumulated deficit of $199.7 million at June 30, 2005. Beginning
in August 2001, we instituted programs to reduce expenses including reducing headcount from 144 employees at the end of July 2001 to 56 employees at the end of December 2003 and reducing employees salaries by 10%. In September 2002 we relocated our
headquarters which reduced rent expense and canceled our Directors and Officers Liability Insurance policy which reduced insurance expense. These actions resulted in significant cost savings in 2003. We reduced our cash used in operating activities
from approximately $13.0 million in 2002 to approximately $4.1 million in 2003. However, for the nine month transition period ended September 30, 2004, cash used in operating activities increased to $9.1 million and for the nine months ended June
30, 2005, cash used in operating activities was $8.6 million.



We, as well as
certain of our directors and current and former officers have been named as defendants in certain legal proceedings described in this Form 10-Q (see Part II Item 1 Legal Proceedings). We do not have third party insurance coverage for
either the costs of defending these legal proceedings, including the costs of possible indemnification claims by the individual named defendants, or any potential settlement payments. The costs of defending or settling these legal proceedings will
likely be significant. At this time we are not able to accurately estimate the costs of the defense or of a potential settlement, as the defendants were just served during the quarter ended March 31, 2005, but we believe that these costs will have a
material adverse effect on our cash balances and will be another factor requiring the Company to raise additional funds.



During fiscal 2004, warrants were exercised which resulted in us receiving proceeds totaling approximately $2.3 million. In addition, in August 2004 we raised $5.0
million through a financing and in March 2005 we completed a private placement of common stock and common stock purchase warrants that resulted in gross proceeds of approximately $4.4 million. At June 30, 2005, we had working capital of $1.9
million, including cash of $2.2 million.



26



---

##### Table of Contents

We will need to raise additional funds to finance our activities through public or private equity or debt financings, the
formation of strategic partnerships or alliances with other companies or through bank borrowings with existing or new banks. We may not be able to obtain additional funds on terms that would be favorable to our stockholders and us, or at all. In
such instance, we will take measures to reduce our operating expenses, such as reducing headcount or canceling selected research and development projects. Additionally, pursuant to the terms of a private placement transaction under which we sold
4,833,335 shares of our common stock in March 2005 (the Private Placement), we are prohibited from filing additional registration statements until 60 days after the registration statement covering the resale of the shares issued in the
Private Placement (Registration No. 333-123551) (the Registration Statement) is declared effective, except Form S-8 registration statements in connection with employee stock benefit plans, upon exercise or conversion of outstanding
securities and pursuant to acquisitions or other strategic transactions that are not primarily for the purpose of raising additional capital. We are also subject to certain cash penalties payable to the selling stockholders that purchased shares in
the Private Placement under certain circumstances relating to the timely filing, effectiveness and maintenance of effectiveness of the Registration Statement. Our future is dependent upon obtaining sufficient financing as needed to fund current
working capital needs and future growth, and ultimately on achieving profitability. We have taken a two-pronged approach to reach these goals. First we intend to engage in an equity or debt financing within the next few months and we are reducing
inventory levels and creating what we believe to be sustainable unit volume increases with many of our customers which should allow us to increase revenues and reduce manufacturing costs. We cannot be certain that any such financing will be
available on acceptable terms or at all. We cannot assure that the unit volume increase with our customers will in fact be sustainable or that our revenue will increase or our manufacturing costs will decrease.



Recent Accounting Pronouncements



In November 2004, the FASB issued SFAS No. 151, Inventory Costsan amendment of
ARB No. 43, Chapter 4. (SFAS 151). SFAS 151 amends ARB 43, Chapter 4 to clarify that abnormal amounts of idle freight, handling costs and spoilage should be recognized as current period charges. SFAS 151 is effective
for inventory costs incurred during fiscal years beginning after June 15, 2005. We do not anticipate that the adoption of this standard will have a material impact on our consolidated financial statements.



In December 2004, the FASB issued SFAS No. 152 Accounting for Real Estate Time-Sharing
Transactionsan amendment of FASB statements No. 66 and 67 (SFAS 152). SFAS 152 amends SFAS 66 and 67 to reference the financial accounting and reporting guidance for real estate time-sharing transactions that is provided in
AICPA Statement of Position (SOP) 04-2, Accounting for Real Estate Time-Sharing Transactions. SFAS 152 is effective for financial statement for fiscal years beginning after June 15, 2005. We do not anticipate that the adoption of this standard will
have a material impact on our consolidated financial statements.



In December
2004, the FASB issued SFAS No. 153 Exchanges of Non-monetary Assetsan amendment of APB opinion No. 29 (SFAS 153). SFAS 153 clarifies that exchanges of non-monetary assets should be measured based on the fair value of
the assets exchanged, with a general exception for exchanges that have no commercial substance. SFAS 153 is effective for non-monetary asset exchanges occurring in fiscal periods beginning after June 15, 2005. We do not anticipate that the adoption
of this standard will have a material impact on our consolidated financial statements.



In December 2004, the FASB revised SFAS No. 123 (SFAS 123 (R)). SFAS 123 (R), Share-Based Payment, requires all share-based payments to employees, including grants of employee stock options, to be recognized in the
financial statements based on their fair values. Pro forma disclosure is no longer an alternative to financial statement recognition. SFAS 123 (R) is effective for periods beginning after June 15, 2005.



27



---

##### Table of Contents

On April 14, 2005, the SEC announced the adoption of a new rule that amended the compliance dates for SFAS 123 (R). Under
the new rule, companies are allowed to implement SFAS 123 (R) at the beginning of the next fiscal year, instead of the next reporting period, that begins after June 15, 2005. We are required to comply with SFAS 123 (R) beginning with our fiscal
quarter ending December 31, 2005. SFAS 123 (R) provides transition alternatives for public companies to restate prior interim periods or prior years. We are still evaluating the transition provisions allowed by SFAS 123 (R).



In March 2005, the SEC released SEC Staff Accounting Bulletin No. 107, Share-Based
Payment (SAB 107). SAB 107 provides the SEC staffs position regarding the application of SFAS 123 (R) and certain SEC rules and regulations, and also provides the staffs views regarding the valuation of share-based
payment arrangements for public companies. We are currently reviewing the effect, if any, that the application of SAB 107 will have on our financial position and results of operations.



In March 2005, the FASB issued FASB Interpretation No. 47, Accounting for Conditional Asset Retirement Obligations (FIN
47), which clarifies the term conditional asset retirement obligations as used in SFAS No. 143, Accounting for Asset Retirement Obligations. We do not anticipate that the application of FIN 47 will have a material
impact on our financial position and results of operations.



In May 2005, the
FASB issued SFAS No. 154 Accounting Changes and Error Corrections  a replacement of APB Opinion No. 20, and FASB Statement No. 3. (SFAS 154). SFAS 154 replaces APB Opinion No. 20, Accounting Changes, and FASB Statement
No. 3, Reporting Accounting Changes in Interim Financial Statements, and changes the requirements for the accounting for and reporting of a change in accounting principle. This statement applies to all voluntary changes in accounting principle. It
also applies to changes required by an accounting pronouncement in the unusual instance that the pronouncement does not include specific transition provisions. When a pronouncement includes specific transition provisions, those provisions should be
followed. SFAS 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 31, 2005. We do not anticipate that the adoption of this standard will have a material impact on our consolidated
financial statements.



Risk Factors



Set forth below and elsewhere in
this quarterly report and in the other documents we file with the Securities and Exchange Commission are risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward looking statements
contained in this quarterly report. Prospective and existing investors are strongly urged to carefully consider the various cautionary statements and risks set forth in this quarterly report and our other public filings.



We need to raise additional capital to continue to grow our business, which may not be
available to us.



We incurred net losses of approximately $8.5 million for
the nine months ended June 30, 2005, $11.6 million for the nine months ended September 30, 2004 and $7.2 million for the twelve months ended December 31, 2003. Because we have had losses, we have funded our operating activities to date from the sale
of securities, including our most recent financings in March 2005, August 2004 and January 2002 as well as from the proceeds from the related exercise of warrants issued in connection with the 2002 financing. However, to grow our business
significantly and to fund additional losses, we will need additional capital. We cannot be certain that any such financing will be available on acceptable terms, or at all. Moreover, additional equity financing, if available, would likely be
dilutive to the holders of our common stock, and debt financing, if available, would likely involve restrictive covenants. In addition, pursuant to the terms of the March 2005 private transaction under which we sold shares offered to the selling
stockholders, we are prohibited from issuing additional securities until 60 days after the registration statement is declared effective, except pursuant to employee stock benefit plans, upon exercise or conversion of outstanding securities and
pursuant to acquisitions or other strategic transactions that are not primarily for the purpose of raising additional capital. We can provide no assurance as to when this registration statement will be declared effective. We are also subject to
certain cash penalties payable to the selling stockholders under certain circumstances relating to the timely filing, effectiveness and maintenance of effectiveness of the registration statement. If we cannot raise sufficient additional capital, it
would adversely affect our ability to achieve our business objectives and to continue as a going concern.



We may not maintain Nasdaq National Market listing requirements.



On April 25, 2005 we received a deficiency notice from the Nasdaq Stock Market, or Nasdaq, for failing to (1) maintain the Nasdaq National Markets minimum $50 million market value of listed securities
requirement for continued listing and (2) maintain our total assets and total revenue for the most recently completed fiscal year or for two of the last three most recently completed fiscal years above the $50 million requirement for continued
listing. We had a grace period of 30 calendar days, or until May 25, 2005, to cure the deficiency by meeting the $50 million minimum market value of listed securities for 10 consecutive days or such longer period of time



28



---

##### Table of Contents

as may be required by Nasdaq, at its discretion. Based upon 55,349,746 shares outstanding as of April 20, 2005, our stock price would have to equal or exceed
approximately $0.91 for a minimum of 10 consecutive trading days. If we failed to meet the minimum market value of listed securities for a minimum of 10 consecutive trading days during the grace period, our common stock may be delisted from the
Nasdaq National Market. We did not meet this requirement during the 30 calendar days referenced in the letter. There can be no assurance that we will regain or maintain compliance with the minimum market value of listed securities requirement in the
future.



In addition, on April 26, 2005, we received a deficiency notice from
Nasdaq for failing to maintain the Nasdaq National Markets minimum $1.00 bid price requirement for continued listing. We have a grace period of 180 calendar days, or until October 24, 2005, to cure the deficiency by meeting the minimum $1.00
bid price for 10 consecutive trading days or such longer period of time as may be required by Nasdaq, at its discretion. There can be no assurance that we will regain or maintain compliance with the minimum bid price. If we fail to meet the minimum
bid price for 10 consecutive days during the grace period, our common stock may be delisted from the Nasdaq National Market. As of July 22, 2005, our common stock has not closed at or above $1.00 per share for a minimum of 10 consecutive trading
days since receipt of the April 26, 2005 letter.



On May 26, 2005, we received
another letter from Nasdaq notifying us that we had not regained compliance with Marketplace Rule 4450(b)(1)(A), which sets a $50 million market value of listed securities requirement for continued listing, during the relevant grace period.
According to this letter, we are subject to delisting from the Nasdaq National Market. We appealed Nasdaqs determination and a hearing before a Nasdaq Listing Qualifications Panel was held on July 14, 2005. We have not received the final
Listing Qualifications Panel determination with respect to our appeal. If we are unsuccessful in our appeal, we have requested that the Listing Qualifications Panel transfer our listing to the Nasdaq SmallCap Market. We believe that we meet all of
the Nasdaq SmallCap Markets continued listing requirements (other than the minimum bid price requirement of $1.00, for which there is an applicable grace period), but there can be no assurance that the Panel will agree to transfer our listing.
Our common stock will remain listed on the Nasdaq National Market while our appeal is pending before the Listing Qualifications Panel.



There is no assurance that we will receive a favorable decision from the Listing Qualifications Panel or that we will satisfy the Nasdaqs continued listing
requirements in the future, with the result that our common stock may be delisted from the Nasdaq National Market. Should our common stock be delisted from the Nasdaq National Market, it would likely be traded on the Nasdaq SmallCap Market or on the
Over the Counter (OTC) Bulletin Board of the National Association of Securities Dealers, Inc. If our common stock is delisted from the Nasdaq National Market or the Nasdaq SmallCap Market, it would likely be more difficult to trade in or obtain
accurate quotations as to the market price of our common stock. Delisting of our common stock could materially adversely affect the market price, the market liquidity of our common stock, and our ability to raise necessary capital and could
otherwise have an adverse impact on our business, financial condition, and results of operations.



We have a history of losses and may never achieve or sustain profitability.



As of June 30, 2005, we had an accumulated deficit of $199.7 million. We incurred net losses of approximately $8.5 million for the nine months ended June 30, 2005, $11.7
million for the nine months ended September 30, 2004 and $7.2 million for the twelve months ended December 31, 2003. We may continue to incur net losses and these losses may be substantial. Furthermore, we may continue to generate significant
negative cash flow in the future. We will need to generate substantially higher revenue to achieve and sustain profitability and positive cash flow. Our ability to generate future revenue and achieve profitability will depend on a number of factors,
many of which are described throughout this section. If we are unable to achieve or maintain profitability, we will be unable to build a sustainable business. In this event, our share price and the value of your investment would likely decline and
we might be unable to continue as a going concern.



29



---

##### Table of Contents

Our quarterly operating results are likely to fluctuate significantly and may fail to meet the expectations of
securities analysts and investors, which may cause our share price to decline.



Our quarterly operating results have fluctuated significantly in the past and are likely to continue to do so in the future. The many factors that could cause our quarterly results to fluctuate include, in part:



| |  |  | level of sales and recognition of revenue;
| | - |  | ------------------------------------------



| |  |  | mix of high and low margin products;
| | - |  | ------------------------------------



| |  |  | availability and pricing of wafers;
| | - |  | -----------------------------------



| |  |  | timing of introducing new products, including, but not limited to, the introduction of new products based on the lower cost Godzilla architecture, lower cost versions of
existing products, fluctuations in manufacturing yields and other problems or delays in the fabrication, assembly, testing or delivery of products;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | rate of development of target markets; and
| | - |  | ------------------------------------------



| |  |  | increases in inventory reserves associated with slow moving, excess and obsolete inventory.
| | - |  | -------------------------------------------------------------------------------------------



A large portion of our operating expenses, including salaries, rent and capital lease expenses, are fixed. If we experience a shortfall in
revenues relative to our expenses, we may be unable to reduce our expenses quickly enough to offset the reduction in revenues during that accounting period, which would adversely affect our operating results. Fluctuations in our operating results
may also result in fluctuations in our common stock price. If the market price of our stock is adversely affected, we may experience difficulty in raising capital or making acquisitions. In addition, we may become the object of securities class
action litigation, which occurred in late 2004. As a result, we do not believe that period-to-period comparisons of our revenues and operating results are necessarily meaningful. One should not rely on the results of any one quarter as an indication
of future performance.



Our stock price may be subject to significant
volatility.



The stock prices for many technology companies have recently
experienced large fluctuations, which may or may not be directly related to the operating performance of the specific companies. For example, during the calendar year 2004, our common stock had closing sales prices on Nasdaq as low as $0.77 and as
high as $8.20 per share. Broad market fluctuations as well as general economic conditions may cause our stock price to decline. We believe that fluctuations of our stock price may continue to be caused by a variety of factors, including:



| |  |  | announcements of developments related to our business;
| | - |  | ------------------------------------------------------



| |  |  | fluctuations in our financial results;
| | - |  | --------------------------------------



| |  |  | general conditions in the stock market or around the world, terrorism or developments in the semiconductor and capital equipment industry and the general economy;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | sales or purchases of our common stock in the marketplace;
| | - |  | ----------------------------------------------------------



| |  |  | announcements of our technological innovations or new products or enhancements or those of our competitors;
| | - |  | -----------------------------------------------------------------------------------------------------------



| |  |  | developments in patents or other intellectual property rights;
| | - |  | --------------------------------------------------------------



| |  |  | developments in our relationships with customers and suppliers;
| | - |  | ---------------------------------------------------------------



| |  |  | a shortfall or changes in revenue, gross margins or earnings or other financial results from analysts expectations or an outbreak of hostilities or natural disasters; or
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | acquisition or merger activity and the success in implementing such acquisitions.
| | - |  | ---------------------------------------------------------------------------------



30



---

##### Table of Contents

Our product shipment patterns make it difficult to predict our quarterly revenues.



As is common in our industry, we frequently ship more products in the third month of each
quarter than in either of the first two months, and shipments in the third month are higher at the end of that month than at the beginning. We believe this pattern is likely to continue. The concentration of sales in the last month of the quarter
may cause our quarterly results of operations to be more difficult to predict. Moreover, if sufficient business does not materialize or a disruption in our production or shipping occurs near the end of a quarter, our revenues for that quarter could
be materially affected.



Our customers may cancel or defer product orders,
which could result in excess inventory.



Our sales are generally made
pursuant to individual purchase orders that may be canceled or deferred by customers on short notice without significant penalty. Thus, orders in backlog may not result in future revenue. In the past, we have had cancellations and deferrals by
customers. Any cancellation or deferral of product orders could result in us holding excess inventory, or result in obsolete inventory over time, which could seriously harm our profit margins and restrict our ability to fund our operations. For
example, during the quarter ended September 30, 2004, we recorded a provision for slow moving, excess and obsolete inventory of approximately $4.3 million. Our inventory and purchase commitments are based on expected demand and not necessarily built
for firm purchase commitments for our customers. Because of the required delivery lead time, we need to carry a high level of inventory in comparison to past sales. We recognize revenue upon shipment of products to the end customer and, in the case
of distributor sales, based upon receipt of point-of-sales report from the distributor. Although we have not experienced customer refusals to accept shipped products or material difficulties in collecting accounts receivable, such refusals or
collection difficulties are possible and could result in significant charges against income, which could seriously harm our revenues and our cash flow.



We rely on a small number of customers and sales by distributors for most of our revenue and a decrease in revenue from these customers could seriously harm our
business.



A relatively small number of customers have accounted for most
of our revenues to date. Any reduction or delay in sales of our products to one or more of these key customers could seriously reduce our sales volume and revenue and adversely affect our operating results. Our top five end customers accounted for
46% of revenue in the nine month period ended June 30, 2005, 65% of revenue in the transition period ended September 30, 2004 and 68% of revenue in 2003. Our primary customers in the nine months ended June 30, 2005 were Sharp, Kyoshin Technosonic
Co., Ltd. (KTS) and Beko representing 18%, 8% and 8% respectively of our revenue. Our primary end customers in the transition period ended September 30, 2004 were KTS, Alcatel and Samsung representing 28%, 19% and 9% of revenue,
respectively. In 2003, our primary end customers were KTS, Samsung and Apple representing 24%, 18% and 15% of revenue, respectively. We expect that we will continue to rely on the success of our largest customers and on our success in selling our
existing and future products to those customers in significant quantities. In addition, approximately 53% of our revenue both in the nine month period ended June 30, 2005 and transition period ended September 30, 2004, were from our largest
distributor, Macnica. We cannot be sure that we will retain our largest customers (whether from inside sales or through our distributors) or that we will be able to obtain additional key customers or replace key customers we may lose or who may
reduce their purchases.



We currently rely on sales of one product for a
significant portion of our revenue, and the failure of this product to be successful in the future could substantially reduce our sales.



We currently rely on sales of our TA2024 digital audio amplifier product to generate a significant portion of our revenue. Sales of this product amounted to 56% of our
revenue for the nine months ended June 30, 2005, 35% of our revenue for the nine months ended September 30, 2004, and 39% of our revenue for the twelve months ended December 31, 2003. We have developed additional products and plan to introduce more
products in the future, but there can be no assurance that these products will be commercially successful. Consequently, if our existing products are not successful, our sales could decline substantially.



31



---

##### Table of Contents

Our lengthy sales cycle makes it difficult for us to predict if or when a sale will be made, to forecast our revenue
and to budget expenses, which may cause fluctuations in our quarterly results.



Because of our lengthy sales cycles, we may continue to experience a delay between incurring expenses for research and development, sales and marketing and general and administrative efforts, as well as incurring investments in inventory,
and the generation of revenue, if any, from such expenditures. In addition, the delays inherent in such a lengthy sales cycle raise additional risks of customer decisions to cancel or change product plans, which could result in our loss of
anticipated sales. Our new products are generally incorporated into our customers products or systems at the design stage. To try and have our products selected for design into new products of current and potential customers, commonly referred
to as design wins, often requires significant expenditures by us without any assurance of success. Once we have achieved a design win, our sales cycle will start with the test and evaluation of our products by the potential customer and design of
the customers equipment to incorporate our products. Generally, different parts have to be redesigned to incorporate our devices successfully into our customers products.



The sales cycle for the test and evaluation of our products can range from a minimum of three to six months, and it can take a minimum of an
additional six to nine months before a customer commences volume production of equipment that incorporates our products. Achieving a design win provides no assurance that such customer will ultimately ship products incorporating our products or that
such products will be commercially successful. Our revenue or prospective revenue would be reduced if a significant customer curtails, reduces or delays orders during our sales cycle, or chooses not to release products incorporating our products.



Our ability to achieve revenue growth will be harmed if we are unable to
persuade electronic systems manufacturers to adopt our new amplifier technology.



We face difficulties in persuading manufacturers to adopt our products using our new amplifier technology. Traditional amplifiers use design approaches developed in the 1930s. These approaches are still used in most amplifiers and engineers
are familiar with these design approaches. To adopt our products, manufacturers and engineers must understand and accept our new technology. To take advantage of our products, manufacturers must redesign their systems, particularly components such
as the power supply and heat sinks. Manufacturers must work with their suppliers to obtain modified components and they often must complete lengthy evaluation and testing. In addition, our amplifiers are often more expensive as components than
traditional amplifiers. For these reasons, prospective customers may be reluctant to adopt our technology.



We currently depend on consumer electronics markets that are typically characterized by aggressive pricing, frequent new product introductions and intense competition.



A substantial portion of our current revenue is generated from sales of products that
address the consumer electronics markets, including home theater, computer audio, flat panel TV, gaming, professional amplifiers, set-top box, AV receivers and the automotive audio markets. These markets are characterized by frequent new product
introductions, declining prices and intense competition. Pricing in these markets is aggressive, and we expect pricing pressure to continue. In the computer audio segment, our success depends on consumer awareness and acceptance of existing and new
products by our customers and consumers, in particular, the elimination of externally-powered speakers. In the automotive audio segment, we face pressure from our customers to deliver increasingly higher-powered solutions under significant
engineering limitations due to the size constraints in car dashboards. In addition, our ability to obtain prices higher than the prices of traditional amplifiers will depend on our ability to educate manufacturers and their customers about the
benefits of our products. Failure of our customers and consumers to accept our existing or new products will seriously harm our operating results.



The cyclical nature of the semiconductor industry could create fluctuations in our operating results.



The semiconductor industry has historically been cyclical and characterized by wide
fluctuations in product supply and demand. From time to time, the industry has also experienced significant downturns, often in connection with, or in anticipation of, maturing product cycles and declines in general economic conditions.



32



---

##### Table of Contents

Industry downturns have been characterized by diminished product demand, production overcapacity and accelerated decline in average selling prices, and in
some cases have lasted for more than a year. In addition, we may determine to lower our prices of our products to increase or maintain market share, which would likely harm our operating results. The semiconductor industry also periodically
experiences increased demand and production capacity constraints. As a result, we have experienced and may experience in the future substantial period-to-period fluctuations in our results of operations due to general semiconductor industry
conditions, overall economic conditions or other factors, many of which are outside our control. Due to these risks, you should not rely on period-to-period comparisons to predict our future performance.



We may experience difficulties in the introduction of new or enhanced products, including
but not limited to the new Godzilla architecture products, that could result in significant, unexpected expenses or delay their launch, which would harm our business.



Our failure or our customers failure to develop and introduce new products successfully and in a timely manner would seriously harm
our ability to generate revenues. Consequently, our success depends on our ability to develop new products for existing and new markets, introduce such products in a timely and cost-effective manner and to achieve design wins. The development of
these new devices is highly complex, and from time to time we have experienced delays in completing the development and introduction of new products. The successful introduction of a new product may currently take up to 18 months. Successful product
development and introduction depends on a number of factors, including:



| |  |  | accurate prediction of market requirements and evolving standards;
| | - |  | ------------------------------------------------------------------



| |  |  | accurate new product definition;
| | - |  | --------------------------------



| |  |  | timely completion and introduction of new product designs;
| | - |  | ----------------------------------------------------------



| |  |  | availability of foundry capacity;
| | - |  | ---------------------------------



| |  |  | achieving acceptable manufacturing yields;
| | - |  | ------------------------------------------



| |  |  | market acceptance of our products and our customers products; and
| | - |  | ------------------------------------------------------------------



| |  |  | market competition.
| | - |  | -------------------



We cannot guarantee success with regard to these factors. We introduced our lower cost Godzilla architecture products in January 2004 and began sampling them in certain customers products in
mid-2004. However, we have not received design-wins for these products to date.



Neither our disclosure controls and procedures nor our internal control over financial reporting can prevent all errors or fraud, and in the past these controls and procedures were not effective and resulted in restatements to our
financial results.



Our management does not expect that our disclosure
controls and procedures or our internal control over financial reporting will prevent all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the
control system will be attained. Furthermore, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in a
cost-effective control system, no evaluation of controls can provide absolute assurance that all misstatements due to error or fraud, if any, may occur and not be detected on a timely basis. These inherent limitations include the possibility that
judgments in decision-making can be faulty and that breakdowns can occur because of errors or mistakes. Our controls and procedures can also be circumvented by the individuals acts of some persons, by collusion of two or more people or by management
override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions. Furthermore, controls



33



---

##### Table of Contents

may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. While we seek to design our
controls and procedures to provide reasonable assurance that information required to be disclosed in our periodic filings is timely disclosed, these inherent limitations expose us to breakdowns in such controls and procedures. For example, while our
certifying officers believed that the design of our controls and procedures would ensure that material information related to the Company would be made known to them on a timely basis, in light of the circumstances underlying the Initial Restatement
and Additional Restatement, these controls and procedures for the financial statement periods covered by the Initial Restatement and Additional Restatement were not effective. We have made certain changes to our internal control over financial
reporting regarding the review of sales orders designed to address these circumstances, although even these improvements to our controls and procedures cannot ensure that all errors or fraud will be prevented.



We depend on three outside foundries for our semiconductor device manufacturing
requirements.



We do not own or operate a fabrication facility, and
substantially all of our semiconductor device requirements are currently supplied by three outside foundries, United Microelectronics Corporation, in Taiwan, STMicroelectronics Group in Europe and Renesas Technology (Mitsubishi Electric) in Japan.
Although we primarily utilize these three outside foundries, most of our components are not manufactured at these foundries at the same time. As a result, each foundry is a sole source for certain products.



There are significant risks associated with our reliance on outside foundries, including:



| |  |  | the lack of guaranteed wafer supply;
| | - |  | ------------------------------------



| |  |  | limited control over delivery schedules, quality assurance and control, manufacturing yields and production costs; and
| | - |  | ----------------------------------------------------------------------------------------------------------------------



| |  |  | the unavailability of or delays in obtaining access to key process technologies.
| | - |  | --------------------------------------------------------------------------------



In addition, the manufacture of integrated circuits is a highly complex and technologically demanding process. Although we work closely with
our foundries to minimize the likelihood of reduced manufacturing yields, our foundries have from time to time experienced lower than anticipated manufacturing yields, particularly in connection with the introduction of new products and the
installation and start-up of new process technologies.



We provide our
foundries with continuous forecasts of our production requirements; however, the ability of each foundry to provide us with semiconductor devices is limited by the foundrys available capacity. In many cases, we place our orders on a purchase
order basis, and foundries may allocate capacity to the production of other companies products while reducing the deliveries to us on short notice. In particular, foundry customers that are larger and better financed than us or that have
long-term agreements with our foundries may cause such foundries to reallocate capacity in a manner adverse to us. While capacity at our foundries has been available during the last several years, the cyclical nature of the semiconductor industry
could result in capacity limitations in a cyclical upturn or otherwise.



If we
use a new foundry, several months would be typically required to complete the qualification process before we can begin shipping products from the new foundry. In the event any of our current foundries suffers any damage or destruction to their
respective facilities, or in the event of any other disruption of foundry capacity, we may not be able to qualify alternative manufacturing sources for existing or new products in a timely manner. Even our current outside foundries would need to
have certain manufacturing processes qualified in the event of disruption at another foundry, which we may not be able to accomplish in a timely enough manner to prevent an interruption in supply of the affected products.



If we encounter shortages or delays in obtaining semiconductor devices for our products in
sufficient quantities when required, delivery of our products could be delayed, resulting in customer dissatisfaction and decreased revenues.



34



---

##### Table of Contents

We depend on third-party subcontractors for most of our semiconductor assembly and testing requirements and any
unexpected interruption in their services could cause us to miss scheduled shipments to customers and to lose revenues.



Semiconductor assembly and testing are complex processes, which involve significant technological expertise and specialized equipment. As a result of our reliance on
third-party subcontractors for assembly and testing of our products, we cannot directly control product delivery schedules, which has in the past, and could in the future, result in product shortages or quality assurance problems that could increase
the costs of manufacture, assembly or testing of our products. Almost all of our products are assembled and tested by one of five subcontractors: ASE in Korea, Malaysia and Taiwan, Hon Hai (formerly AMBIT Microsystems Corporation) in China, Lingsen
in Taiwan, STMicroelectronics Group in Malaysia, and ST Assembly Test Services Ltd. in Singapore. We do not have long-term agreements with any of these suppliers and retain their services on a per order basis. The availability of assembly and
testing services from these subcontractors could be adversely affected in the event a subcontractor suffers any damage or destruction to their respective facilities, or in the event of any other disruption of assembly and testing capacity. Due to
the amount of time normally required to qualify assemblers and testers, if we are required to find alternative manufacturing assemblers or testers of our components, shipments could be delayed. Any problems associated with the delivery, quality or
cost of our products could seriously harm our business.



Failure to
transition our products to more effective and/or increasingly smaller semiconductor chip sizes and packaging could cause us to lose our competitive advantage and reduce our gross margins.



We evaluate the benefits, on a product-by-product basis, of migrating to smaller
semiconductor process technologies in order to reduce costs and have commenced migration of some products to smaller semiconductor processes. We believe that the transition of our products to increasingly smaller semiconductor processes will be
important for us to reduce manufacturing costs and to remain competitive. Moreover, we are dependent on our relationships with our foundries to migrate to smaller semiconductor processes successfully. We cannot be sure that our future process
migrations will be achieved without difficulties, delays or increased expenses. Our gross margins would be seriously harmed if any such transition is substantially delayed or inefficiently implemented.



Our international operations subject us to risks inherent in doing business on an
international level that could harm our operating results.



We currently
obtain almost all of our manufacturing, assembly and test services from suppliers located outside the United States and may expand our manufacturing activities abroad. Approximately 95% and 94%, respectively, of our total revenue for the nine months
ended June 30, 2005 and for the nine months ended September 30, 2004, was derived from sales to end customers based outside the United States. In 2003, 88% of our total revenue was derived from sales to end customers based outside of the United
States. In addition, we often ship products to our domestic customers international manufacturing divisions and subcontractors.



Accordingly, we are subject to risks inherent in international operations, which include:



| |  |  | political, social and economic instability;
| | - |  | -------------------------------------------



| |  |  | trade restrictions and tariffs;
| | - |  | -------------------------------



| |  |  | the imposition of governmental controls;
| | - |  | ----------------------------------------



| |  |  | exposure to different legal standards, particularly with respect to intellectual property;
| | - |  | ------------------------------------------------------------------------------------------



| |  |  | import and export license requirements;
| | - |  | ---------------------------------------



| |  |  | unexpected changes in regulatory requirements; and
| | - |  | --------------------------------------------------



| |  |  | difficulties in collecting receivables.
| | - |  | ---------------------------------------



All of our international sales to date have been denominated in U.S. dollars. As a result, an increase in the value of the U.S. dollar relative to foreign currencies
could make our products less competitive in international markets. Conversely, a decrease in the value of the U.S. dollar relative to foreign currencies would increase the cost of our overseas manufacturing, which would reduce our gross margins.



35



---

##### Table of Contents

If we are not successful in developing and marketing new and enhanced products for the DSL high speed communications
markets that keep pace with technology and our customers needs, our operating results will suffer.



The market for our DSL products is new and emerging, and is characterized by rapid technological advances, intense competition and a relatively small number of potential customers. This will likely result in price
erosion on existing products and pressure for cost-reduced future versions. Implementation of our products requires manufacturers to accept our technology and redesign their products. If potential customers do not accept our technology or experience
problems implementing our devices in their products, our products could be rendered obsolete and our business would be harmed. If we are unsuccessful in introducing future products with enhanced performance, our ability to achieve revenue growth
will be seriously harmed.



We may experience difficulties in the development
and introduction of a new amplifier product for use in the cellular phone market, which could result in significant expenses or delay in its launch.



We are currently developing an amplifier product for use in the cellular phone market. This product is still in research and development and we currently have no design
wins or customers for this product. We may not introduce our amplifier product for the cellular phone market on time, and this product may never achieve market acceptance. Furthermore, competition in this market is likely to result in price
reductions, shorter product life cycles, reduced gross margins and longer sales cycles compared with what we have experienced to date with our other products.



Intense competition in the semiconductor industry and in the consumer electronics and communications markets could prevent us from achieving or sustaining
profitability.



The semiconductor industry and the consumer audio and
communications markets are highly competitive. We compete with a number of major domestic and international suppliers of semiconductors in the consumer electronics and communications markets. We also may face competition from suppliers of products
based on new or emerging technologies. Many of our competitors operate their own fabrication facilities and have longer operating histories and presence in key markets, greater name recognition, access to larger customer bases and significantly
greater financial, sales and marketing, manufacturing, distribution, technical and other resources than us. As a result, such competitors may be able to adapt more quickly to new or emerging technologies and changes in customer requirements or
devote greater resources to the promotion and sale of their products than us. Current and potential competitors have established or may establish financial or strategic relationships among themselves or with existing or potential customers,
resellers or other third parties. Accordingly, it is possible that new competitors or alliances among competitors could emerge and rapidly acquire significant market share. In addition, existing or new competitors may in the future develop
technologies that more effectively address the transmission of digital information through existing analog infrastructures at a lower cost or develop new technologies that may render our technology obsolete. There can be no assurance that we will be
able to compete successfully in the future against our existing or potential competitors, or that our business will not be harmed by increased competition.



Our products are complex and may have errors and defects that are detected only after deployment in customers products, which may harm our business.



Products such as those that we offer may contain errors and defects when
first introduced or as new versions are released. We have in the past experienced such errors and defects, in particular in the development stage of a new product. Delivery of products with production defects or reliability, quality or compatibility
problems could significantly delay or hinder market acceptance of such products, which could damage our reputation and seriously harm our ability to retain our existing customers and to attract new customers and therefore impact our



36



---

##### Table of Contents

revenues. Moreover, such errors and defects could cause problems, interruptions, delays or a cessation of sales to our customers. Alleviating such problems
may require substantial redesign, manufacturing and testing which would result in significant expenditures of capital and resources. Despite testing conducted by us, our suppliers and our customers, we cannot be sure that errors and defects will not
be found in new products after commencement of commercial production. Such errors and defects could result in additional development costs, loss of, or delays in, market acceptance, diversion of technical and other resources from our other
development efforts, product repair or replacement costs, claims by our customers or others against us or the loss of credibility with our current and prospective customers. Any such event could result in the delay or loss of market acceptance of
our products and would likely harm our business.



We do not have third party
insurance coverage to offset the cost of defending the pending securities class action and derivative litigation and, therefore, defending the litigation matters set forth in this quarterly report on Form 10-Q will likely materially and adversely
affect our financial condition.



Our financial condition will likely be
materially adversely affected by the pendency of the litigation referenced in this Quarterly Report on Form 10-Q because we do not have third-party insurance coverage for either the costs of defending these lawsuits, including the costs of possible
indemnification claims by the individual named defendants, or settling such litigation. We believe that the cost of defending or settling such litigation will have a material adverse effect on our cash balances and will be another factor requiring
us to raise additional funds. In addition, these matters will require devotion of significant management resources which may also adversely affect our business operations.



If we are unable to retain key personnel, we may not be able to operate our business successfully.



We may not be successful in retaining executive officers and other key management and
technical personnel. A high level of technical expertise is required to support the implementation of our technology in our existing and new customers products. In addition, the loss of the management and technical expertise of Dr. Adya S.
Tripathi, our founder, president and chief executive officer, could seriously harm us. We do not have any employment contracts with our employees.



Our intellectual property and proprietary rights may be insufficient to protect our competitive position.



Our business depends, in part, on our ability to protect our intellectual property. We rely
primarily on patent, copyright, trademark and trade secret laws to protect our proprietary technologies. We cannot be sure that such measures will provide meaningful protection for our proprietary technologies and processes. As of June 30, 2005, we
had 38 issued United States patents, and 10 additional United States patent applications which are pending. In addition, we had 17 international patents issued and an additional 26 international patents pending. We cannot be sure that any patent
will issue as a result of these applications or future applications or, if issued, that any claims allowed will be sufficient to protect our technology. In addition, we cannot be sure that any existing or future patents will not be challenged,
invalidated or circumvented, or that any right granted thereunder would provide us meaningful protection. The failure of any patents to provide protection to our technology would make it easier for our competitors to offer similar products. In
connection with our participation in the development of various industry standards, we may be required to agree to license certain of our patents to other parties, including our competitors, that develop products based upon the adopted standards.



We also rely on copyright, trademark and trade secret laws in the United
States and other countries to protect our propriety rights. As discussed above, we have several international issued and pending patents in certain foreign countries. However the laws of some foreign countries in which we do business may not protect
our copyrights, trademarks and trade secrets to the same extent as the laws of the United States. We also generally enter into confidentiality agreements with our employees and strategic partners, and generally control access to and distribution of
our documentation and other proprietary information. Despite these precautions, it may be possible for a third party to copy or otherwise obtain and use our products, services or technology without authorization, develop similar technology
independently or design around our patents. In addition,



37



---

##### Table of Contents

effective copyright, trademark and trade secret protection may be unavailable or limited in certain foreign countries. Some of our customers have entered
into agreements with us pursuant to which such customers have the right to use our proprietary technology in the event we default in our contractual obligations, including product supply obligations, and fail to cure the default within a specified
period of time.



We may be subject to intellectual property rights disputes
that could divert managements attention and could be costly.



The
semiconductor industry is characterized by vigorous protection and pursuit of intellectual property rights. From time to time, we may receive in the future notices of claims of infringement, misappropriation or misuse of other parties
proprietary rights. We cannot be sure that we will prevail in these actions, or that other actions alleging infringement by us of third-party patents, misappropriation or misuse by us of third-party trade secrets or the invalidity of one or more
patents held by us will not be asserted or prosecuted against us, or that any assertions of infringement, misappropriation or misuse or prosecutions seeking to establish the invalidity of our patents will not seriously harm our business. For
example, in a patent or trade secret action, an injunction could be issued against us requiring that we withdraw particular products from the market or necessitating that specific products offered for sale or under development be redesigned. We have
also entered into certain indemnification obligations in favor of our customers and strategic partners that could be triggered upon an allegation or finding of our infringement, misappropriation or misuse of other parties proprietary rights.
Irrespective of the validity or successful assertion of such claims, we would likely incur significant costs and diversion of our management and personnel resources with respect to the defense of such claims, which could also seriously harm our
business. If any claims or actions are asserted against us, we may seek to obtain a license under a third partys intellectual property rights. We cannot be sure that under such circumstances a license would be available on commercially
reasonable terms, if at all. Moreover, we often incorporate the intellectual property of our strategic customers into our designs, and we have certain obligations with respect to the non-use and non-disclosure of such intellectual property.



We cannot be sure that the steps taken by us to prevent our, or our
customers, misappropriation or infringement of intellectual property will be successful.



The facilities of several of our key manufacturers and the majority of our customers, are located in geographic regions with increased risks of natural disasters.



Several key manufacturers and a majority of customers are located in the Pacific Rim region.
The risk of earthquakes in this region, particularly in Taiwan, is significant due to the proximity of major earthquake fault lines. Earthquakes, fire, flooding and other natural disasters in the Pacific Rim region likely would result in the
disruption of our foundry partners assembly and testing capacity and the ability of our customers to purchase our products. Labor strikes or political unrest in these regions would likely also disrupt operations of our foundries and customers.
Any disruption resulting from such events could cause significant delays in shipments of our products until we are able to shift our manufacturing, assembly and testing from the affected contractor to another third party vendor. We cannot be sure
that such alternative capacity could be obtained on favorable terms, if at all. Moreover, any such disruptions could also cause significant decreases in our sales to these customers until our customers resume normal purchasing volumes.



Changes in accounting rules for stock-based compensation may adversely affect our
operating results, our stock price and our competitiveness in the employee marketplace.



We have a history of using employee stock options and other stock-based compensation to hire, motivate and retain our workforce. In December 2004, the Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 123R, Share-Based Payment, to measure compensation costs for all stock- based compensation (including stock options and our employee stock purchase plan) at fair value and to recognize these costs as expenses in
our statements of operations. We are required to comply with SFAS 123 (R) beginning with our fiscal quarter ending December 31, 2005. The recognition of these expenses in our statements



38



---

##### Table of Contents

of operations will result in lower earnings per share, which could negatively impact our future stock price. In addition, if we reduced or alter our use of
stock-based compensation to minimize the recognition of these expenses, our ability to recruit, motivate and retain employees may be impaired, which could put us at a competitive disadvantage in the employee marketplace.



Our independent registered public accounting firm may decline to attest on the adequacy of
our internal controls over financial reporting as required by Section 404 of the Sarbanes-Oxley Act of 2002.



The SEC, as directed by Section 404 of the Sarbanes-Oxley Act of 2002, adopted rules requiring public companies to include a report of management on internal controls
over financial reporting in their annual reports on Form 10-K that contain an assessment by management of the effectiveness of the companys internal controls over financial reporting. In addition, the companys independent registered
public accounting firm must attest to and report on managements assessment of the effectiveness of the internal controls over financial reporting. We are required to comply with Section 404 reporting beginning with our fiscal year ending
September 30, 2005. Although we intend to diligently and vigorously review our internal controls over financial reporting in order to ensure compliance with the Section 404 requirements on an annual basis, if our independent registered public
accounting firm is not satisfied with our internal controls over financial reporting or the level at which these controls are documented, designed, operated or reviewed, or if the independent registered public accounting firm interprets the
requirements, rules and/or regulations differently from us, then they may decline to attest to managements assessment or may issue a report that is qualified. This could result in an adverse reaction in the financial marketplace due to a loss
of investor confidence in the reliability of our consolidated financial statements, which ultimately could negatively impact our stock price.



Terrorist attacks and threats, and government responses thereto, may negatively impact all aspects of our operations, revenues, costs and stock price.



The threat of terrorist attacks involving the United States, the instability in the
Middle East, a decline in consumer confidence and continued economic weakness and geo-political instability have had a substantial adverse effect on the economy. If consumer confidence does not recover, our revenues may be adversely affected for
fiscal 2005 and beyond. Moreover, any further terrorist attacks involving the U.S., or any additional U.S. military actions overseas may disrupt our operations or those of our customers and suppliers. These events have had and may continue to have
an adverse impact on the U.S. and world economy in general and consumer confidence and spending in particular, which could harm our sales. Any of these events could increase volatility in the U.S. and world financial markets which could harm our
stock price and may limit the capital resources available to us and our customers or suppliers. This could have a significant impact on our operating results, revenues and costs and may result in increased volatility in the market price of our
common stock.



We are subject to anti-takeover provisions that could delay
or prevent an unfriendly acquisition of our company.



Provisions of our
restated certificate of incorporation, equity incentive plans, bylaws and Delaware law may discourage transactions involving an unfriendly change in corporate control. In addition to the foregoing, the stockholdings of our officers, directors and
persons or entities that may be deemed affiliates and the ability of our board of directors to issue preferred stock without further stockholder approval could have the effect of delaying, deferring or preventing a third party from acquiring us and
may adversely affect the voting and other rights of holders of our common stock.



Item 3. Quantitative and Qualitative Disclosures about Market Risk



The primary objective of our investment activities is to preserve principal while at the same time maximizing the income we receive from our investments without significantly increasing risk of loss. Some of the
securities that we may acquire in the future may be subject to market risk for changes in interest rates. To mitigate this risk, we plan to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, which may
include commercial paper, money market



39



---

##### Table of Contents

funds, government and non-government debt securities. We manage the sensitivity of our results of operations to these risks by maintaining a conservative
portfolio, which is comprised solely of highly-rated, short-term investments. We do not hold or issue derivative, derivative commodity instruments or other financial instruments for trading purposes. Currently we are exposed to minimal market risks.
Due to the short-term and liquid nature of our portfolio, if interest rates were to fluctuate by 10% from rates at June 30, 2005 and September 30, 2004, our financial position and results of operations would not be materially affected.



Item 4. Controls and Procedures



Controls
Evaluation and Related CEO and CFO Certifications



We have evaluated the
effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. The controls
evaluation was done under the supervision and with the participation of management, including our Chief Executive Officer (CEO) and Chief Financial Officer (CFO) and has allowed us to make conclusions, as set forth below, regarding the state of our
disclosure controls and procedures.



Attached as exhibits to this Quarterly
Report are certifications of the CEO and the CFO, which are required in accordance with Rule 13a-14 of the Exchange Act. This Controls and Procedures section includes the information concerning the controls evaluation referred to in the
certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.



Disclosure Controls and Procedures



Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in our reports filed under the Exchange Act,
such as this Quarterly Report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and forms. Our disclosure controls and procedures are also designed to ensure
that such information is accumulated and communicated to our management, including the CEO and CFO, to allow timely decisions regarding required disclosure. Our disclosure controls include components of our internal control over financial reporting,
which consists of control processes designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the U.S. To
the extent that components of our internal control over financial reporting are included within our disclosure controls, they are included in the scope of our quarterly controls evaluation.



Limitations on the Effectiveness of Controls



Management, including our CEO and CFO, does not expect that our disclosure controls and
procedures or our internal control over financial reporting will prevent all errors or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system
will be attained. Furthermore, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in a cost-effective
control system, no evaluation of controls can provide absolute assurance that all misstatements due to error or fraud, if any, may occur and not be detected on a timely basis. These inherent limitations include the possibility that judgments in
decision-making can be faulty and that breakdowns can occur because of errors or mistakes. Our disclosure controls and procedures can also be circumvented by the individual acts of some persons, by collusion of two or more people or by management
override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions. Furthermore, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.



40



---

##### Table of Contents

Scope of the Controls Evaluation



The evaluation of our disclosure controls and procedures included a review of the controls objectives and design, the Companys
implementation of the controls and the effect of the controls on the information generated for use in this Quarterly Report. During the evaluation of our controls and procedures, we looked to identify data errors, control problems or acts of fraud
and confirm that appropriate corrective action (including process improvements) was being undertaken. This evaluation is performed on a quarterly basis so that the conclusions of management, including the CEO and CFO, concerning the effectiveness of
the disclosure controls and procedures can be reported in our Quarterly Reports on Form 10-Q and to supplement our disclosures made in our Transitional Report on Form 10-K/T. The overall goal of the evaluation activity is to monitor our disclosure
controls and procedures, and to modify them as necessary. We intend to maintain our disclosure controls and procedures as a dynamic system that changes as conditions warrant.



We also considered whether our evaluation identified any significant deficiencies or material weaknesses in our
internal control over financial reporting, and whether we identified any acts of fraud involving personnel with a significant role in our internal control over financial reporting. Emphasis was placed on this information as it was important both for
the controls evaluation and because Item 5 in the certifications of the CEO and CFO requires that they disclose that information to our Board of Directors Audit Committee and to our independent auditors. In the professional auditing
literature, significant deficiencies are defined as a control deficiency, or combination of deficiencies, that adversely affects our ability to initiate, authorize, record, process or report external financial data reliably in accordance
with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of our financial statements that is more than inconsequential will not be prevented or detected. Auditing literature defines
material weakness as a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or
detected.



As previously disclosed in our current report on Form 8-K
dated October 18, 2004 and filed on October 22, 2004, in October 2004, our former independent registered public accountants, BDO Seidman LLP (BDO) provided our Audit Committee with a letter citing what BDO asserted are two material
weaknesses over our internal financial controls: one regarding the lack of effectiveness of our Audit Committee and the other regarding the lack of controls in place to estimate distributor returns in accordance with SFAS No. 48. In response
to this letter, we added an additional independent member to its Board of Directors and Audit Committee who the Board of Directors determined was an Audit Committee Financial Expert, as such term is defined under rules promulgated by the Securities
and Exchange Commission. We believe that there is no material weakness regarding the effectiveness of its Audit Committee following the appointment of such new member. In addition, the Audit Committee instructed our Chief Financial Officer to
conduct an internal investigation as to the verbal concerns raised by BDO regarding the appropriate accounting for approximately $1.3 million of product that, upon our inquiries, one of our distributors, Macnica, reported had been returned to
Macnica by Macnicas customers. The audit committee investigation and discussion that was conducted included a review of the Companys compliance with Securities and Exchange Commission Staff Accounting Bulleting No. 104 Revenue
Recognition in Financial Statements (SAB 104) as applied to the circumstances surrounding the Product Returns (as defined above in Note 16 to the condensed interim consolidated financial statements, Restatement of Previously
Reported Quarterly and Transition Period Financial Information). Under SAB 104, a requirement for revenue recognition is that all of the following criteria must be met: (1) there is persuasive evidence that an arrangement exists, (2) delivery
of goods has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured. In addition, pursuant to the Companys revenue recognition policy, for sales to distributors, the Company defers recognition of
revenue until such time that the distributor sells products to its customers based upon receipt of point-of-sales reports from the distributor. In limited circumstances, revenue may be recognized when sold to a distributor if the distributor
acknowledges in writing that there is no right of return and such sale also otherwise meets the SAB 104 requirements. The internal investigation revealed that approximately $1.4 million of a sale of the Companys product to Macnica did not meet
the foregoing criteria because a former employee of the Company had agreed that Macnica would return the product at Macnicas discretion, which forms the basis of the Restatement. This formeremployee had on this occasion agreed to a term of
sale that was outside of the Companys standard practices and was not referenced in the documentation related to the sale submitted to the Companys finance department. Given the discovery of this arrangement for Macnica to return the
product, the Audit committee concluded on January 25, 2005 that the Company should restate certain financial information that was previously reported in the Companys Form 10-Q for the quarter ended June 30, 2004 filed with the Securities and
Exchange Commission on August 6, 2004 (the Initial Restatement). Following further investigation, the Audit Committee concluded on May 5, 2005 that the Company should restate the financial statements (the Additional
Restatement) that were previously included in its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2004, June 30, 2004, and December 31, 2004 as well as the financial statements for the nine-month transition period ended
September 30, 2004 previously included in its Transition Report on Form 10-K/T. For more information regarding the Initial Restatement and the Additional Restatement, please see Note 16 to our condensed interim consolidated financial statements,
Restatement of Previously Reported Quarterly and Transition Period Financial Information included elsewhere in this Form 10-Q/A. In addition, the Audit Committee approved certain changes to the Companys internal controls over
financial reporting as an additional remedial action.



41



---

##### Table of Contents

Changes in Internal Control Over Financial Reporting.



During the period covered by this Quarterly Report on Form 10-Q, we implemented a
requirement that the point-of-sale reports from our distributors, which are used as part of our revenue recognition policies and indicate shipment by the distributor of our products, include attestation that there are no arrangements related to
rights of return, pricing, discounting, or other marketing concessions that are not contained in the operative sales agreement or related purchase order for the sale transaction and that there is a corresponding valid purchase order from the end
customer for the sale of the product that is the subject of the point-of-sale report. In addition, before sales from distributors are recognized, the distributor certifies to us that the final sales agreement and/or invoice include all of the terms
related to the sale and return of our products and that copies of such agreements and/or invoices are delivered to us at the same time as the order confirmation.



Conclusions



Based upon the evaluation of the effectiveness of our disclosure controls and procedures, our CEO and CFO have concluded that as of the end of the period covered by this
Quarterly Report, our disclosure controls and procedures were effective to provide reasonable assurance that material information required to be included in our Exchange Act reports, including this Quarterly Report on Form 10-Q is made known to
management, including the CEO and CFO, on a timely basis. There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2005, that has materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.



While we
seek to design our controls and procedures to provide reasonable assurance that information required to be disclosed in our periodic filings is timely disclosed, inherent limitations expose us to breakdowns in such controls and procedures. While our
certifying officers believed that the design of our controls and procedures would ensure that material information related to the Company would be made known to them on a timely basis, in light of the circumstances underlying the Initial Restatement
and the Additional Restatement, these controls and procedures for the financial statement periods covered by the Initial Restatement and the Additional Restatement were not effective. We have made certain changes to our internal control over
financial reporting regarding the review of sales orders designed to address these circumstances, as further described above, although even these improvements to our controls and procedures cannot ensure that all errors or fraud will be prevented.



42



---

##### Table of Contents

PART II. Other Information



Item 1. Legal Proceedings



We are a party to
lawsuits in the normal course of our business. Litigation in general, and securities litigation in particular, can be expensive and disruptive to normal business operations. Moreover, the results of legal proceedings are difficult to predict. In
addition, given our financial condition and that we do not have insurance to offset the cost of litigation, the costs of defending one or more of these lawsuits will likely adversely affect our financial condition. We cannot estimate the loss or
range of loss that may be reasonably possible for any of the contingencies described and accordingly have not recorded any associated liabilities in our consolidated balance sheets. We accrue legal costs when incurred.



SEC Investigation



On or about November 9, 2004, the U.S. Securities and Exchange Commission ( the
SEC) requested that we voluntarily produce documents responsive to certain document requests in the investigation entitledIn the Matter of Tripath Technology, Inc. On or about January 25, 2004, February 14, 2005, and February 16,
2005, the SEC made additional documents requests. On or about March 30, 2005, the SEC issued a subpoena to us seeking additional documents. We have produced documents and are continuing to produce documents in response to the SECs voluntary
requests for documents as well as the subpoena. We have cooperated with the SEC in its review of these matters.



On or about February 24, 2005, the SEC, pursuant to Section 20(a) of the Securities Act and Section 21(a) of the Exchange Act, issued a formal order of private
investigation to determine whether there have been any violations of Section 17(a) of the Securities Act and Sections 10(b), 13(a), 13(b)(2)(A), 13(b)(2)(B) and 13(b)(5) of the Exchange Act and Rules 10b-5, 12b-20, 13a-13, 13a-14, 13b2-1 and 13b2-2
thereunder.



Federal Securities Class Actions



Beginning on November 4, 2004, plaintiffs filed four separate complaints
purporting to be class actions in the United States District Court for the Northern District of California alleging that we and certain of our officers and/or directors violated Sections 10(b) and 20(a) of the Exchange Act. Plaintiffs purport to
represent a putative class of shareholders who purchased or otherwise acquired Tripath securities between January 29, 2004 and October 22, 2004. The complaints contain varying allegations, including that we and the individual defendants made
materially false and misleading statements with respect to our financial results and with respect to our business, prospects and operations in the our filings with the SEC, press releases and other disclosures. The complaints seek unspecified
compensatory damages, attorneys fees, expert witness fees, costs and such other relief as may be awarded by the Court.



On December 22, 2004, the Court entered a stipulation and order consolidating all of these complaints and ordering that the defendants need not respond to any of these
complaints until after plaintiffs file a consolidated complaint. On January 4, 2005, plaintiffs filed motions for the appointment of lead plaintiff. The Court, by Order dated January 28, 2005, appointed Robert Poteet as the sole lead plaintiff and
approved Milberg Weiss Bershad & Schulman LLP as lead counsel.



On July 11,
2005, the Company entered into a Stipulation and Settlement Agreement (the Stipulation) which was filed with the Court on July 12, 2005. The settlement class consists of all persons who purchased the securities of Tripath between January
29, 2004 and June 13, 2005, inclusive. Under the terms of the Stipulation, the parties agreed that the class action will be dismissed in exchange for a payment of $200,000 in cash by Tripath and the issuance of 2.45 million shares of Tripath common
stock which shall be exempt from registration pursuant to Section 3(a)(10) of the Securities Act of 1933. The Stipulation remains subject to the satisfaction of various conditions, including without limitation (1) final approval of the Stipulation
by the Court, including a finding that the 2.45 million shares of Tripath common stock to be issued are exempt from registration pursuant to Section 3(a)(1) of the Securities Act of 1933 and (2) notification to members of the settlement class in the
Class Action.



43



---

##### Table of Contents

Derivative Shareholder Litigation



On December 7, 2004, plaintiff Mildred Lyon filed a purported derivative action in Santa Clara Superior Court against us and certain of our
officers and/or directors. This complaint appears to be based upon the same facts and circumstances as the federal class actions and makes the following claims: violation of Section 25402 of the California Corporations Code, breach of fiduciary duty
and misappropriation of information, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. On this basis, the complaint seeks unspecified compensatory damages, treble damages under Section 25502.5(a) of the
California Corporations Code, extraordinary equitable and/or injunctive relief, restitution and disgorgement, attorneys fees, expert witness fees, costs, and such other relief as may be ordered by the Court.



On December 27, 2004, the Court entered a stipulation and order extending the time for us to
respond to the complaint to February 23, 2005. On February 16, 2005, the Court entered an order further extending the time for us to respond to the complaint to March 25, 2005. On March 10, the court ordered that the individual defendants shall have
through and including April 25, 2005 to file any motions to quash and/or dismiss for lack of personal jurisdiction, and that all defendants shall have thirty (30) days from the date the court issues a ruling on any motions to quash and/or dismiss
for lack of personal jurisdiction to respond to the complaint, or in the event that no such motions are brought, extended the time for all defendants to respond to the complaint to April 25, 2005.



On April 4, 2005, the Court ordered that all deadlines shall be stayed for Defendants filing
any motions to quash and/or dismiss for lack of personal jurisdictions, or otherwise respond to the Complaint, until such date as the parties mutually designate to the Court for the Courts approval. A Case Management Conference is scheduled
for August 16, 2005 before the Court. The parties currently are engaged in settlement discussions.



Langley Securities Fraud Litigation



On or about June 2, 2005, plaintiff Langley Partners, L.P. (Langley) filed a complaint in the United States District Court for the Southern District of New
York alleging claims against the Company, Dr. Adya Tripathi, the Companys President and Chief Executive Officer, and David Eichler, the Companys former Chief Financial Officer. Langley alleges that it entered into a stock purchase
agreement with Tripath on or about August 2, 2004 in which Langley purchased 1 million shares of Tripath common stock at a purchase price of $2.00 per share. Langley also alleges that it consented to the receipt of the Companys Prospectus
dated August 2, 2004 and the accompanying Prospectus dated June 1, 2004 which specifically incorporated certain of the Companys filings with the SEC from March through July 2004. The complaint generally alleges that the Company and the
individual defendants made materially false and misleading statements with respect to the Companys financial results and with respect to its business, prospects, internal accounting controls and design wins on Godzilla products in the
Companys filings with the SEC, press releases and other documents. The complaint alleges claims against the Company and the individual defendants for violations of Sections 10(b) and 20(a) of the Exchange Act, fraud, breach of contract, unjust
enrichment and money had and received, rescission and violations of Sections 11 and 15 of the Securities Act. On this basis, the complaint seeks unspecified compensatory damages and restitution in an amount in excess of $2 million, rescission of the
purchase agreement and a return of $2 million, unspecified punitive damages, costs and such other relief as may be awarded by the Court.



On July 12, 2005, the Company served a motion to transfer this action from the Southern District of New York to the United States District Court for the Northern District
of California on plaintiff. The Company filed this motion with the Court on July 20, 2005. This motion has not yet been fully briefed. On June 29, 2005, the Court entered a stipulation and order extending the time for all defendants to respond to
the complaint until August 2, 2005. On July 28, 2005 the Court entered a further stipulation and proposed order extending the time for all defendants to respond to the complaint until 14 days after the Courts ruling on the motion to transfer
or 40 days after all briefing on the motion to transfer is filed, whichever is earlier. A Pre-Trial Conference is scheduled before the Court on August 25, 2005. The Company has not yet responded to the complaint.



Item 6. Exhibits



See Exhibit Index.



44



---

##### Table of Contents

SIGNATURES



Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by undersigned, thereunto duly authorized.



TRIPATH TECHNOLOGY INC.Date: August 9, 2005By:

/s/ JEFFREY L. GARONJeffrey L. Garon Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer)




45



---

##### Table of Contents

EXHIBIT INDEX



|            |  |                                                                                                                                                                               
|----------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Exhibit No. |  | Description                                                                                                                                                                   
|10.1        |  | Business Financing Agreement, dated August 4, 2005, by and between Bridge Bank, National Association and Tripath Technology Inc.                                              
|            | 
|10.2        |  | Intellectual Property Security Agreement, dated August 4, 2005, by and between Bridge Bank, National Association and Tripath Technology Inc.                                  
|            | 
|31.1        |  | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                            
|            | 
|31.2        |  | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                            
|            | 
|32.1        |  | Certification by Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.



46